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RNA-sequencing technologies, which sequence the RNA molecules being 
transcribed in cells, allow us to explore the process of transcription in exquisite detail.  
One of the primary goals of RNA sequencing analysis is to reconstruct the full set of 
transcripts (isoforms) of genes that were present in the original cells.  In addition to 
the transcript structures, experimenters need to estimate the expression levels for all 
transcripts.  The first step in the analysis process is to map the RNA-seq reads against 
the reference genome, which provides the location from which the reads originated.  
In contrast to DNA sequence alignment, RNA-seq mapping algorithms have two 
additional challenges.  First, any RNA-seq alignment program must be able to handle 
gapped alignment (or spliced alignment) with very large gaps due to introns, typically 
from 50-100,000 bases in mammalian genomes.  Second, the presence of processed 
pseudogenes from which introns have been removed may cause many exon-spanning 
reads to map incorrectly. 
  
In order to cope with these problems effectively, I have developed new 
alignment algorithms and implemented them in TopHat2, a second version of TopHat 
(one of the first spliced aligners for RNA-seq reads).  The new TopHat2 program can 
align reads of various lengths produced by the latest sequencing technologies, while 
allowing for variable-length insertions and deletions with respect to the reference 
genome.  TopHat2 combines the ability to discover novel splice sites with direct 
mapping to known transcripts, producing more sensitive and accurate alignments, 
even for highly repetitive genomes or in the presence of processed pseudogenes.  
These new capabilities will contribute to improvements in the quality of downstream 
analysis. 
In addition to its splice junction mapping algorithm, I have developed novel 
algorithms to align reads across fusion break points, which result from the breakage 
and re-joining of two different chromosomes, or from rearrangements within a 
chromosome.  Based on this new fusion alignment algorithm, I have developed 
TransFUSE, one of the first systems for reconstruction and quantification of full-
length fusion gene transcripts.  TransFUSE can be run with or without known gene 
annotations, and it can discover novel fusion transcripts that are transcribed from 
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Chapter 1: Introduction 
1.1 Background: DNA, RNA, Gene, and Protein 
 
Deoxyribonucleic acid (DNA) encodes and serves as stable storage for the 
genetic programs for all forms of life.  DNA is a very long molecule in which two 
strands intertwine with each other to form a double helix structure.  Each strand 
consists of four nucleotides or bases: adenine (A), cytosine (C), guanine (G), and 
thymine (T).  Segments of both strands, called genes, are translated into proteins that 
are directly involved in virtually all aspects of cellular activity.  The size of known 
genomes so far varies from 138 thousand bases (Candidatus Tremblaya princeps) [1] 
to 670 billion bases (Amoebae dubia) [2], where the human genome is about 3 billion 
bases.  It is estimated that our genome contains ~21,000 protein-coding genes [3]. 
Figure 1.1 shows the steps necessary to decode the genetic information, genes, 
to create functioning units, proteins, in eukaryotic cells, including human cells.  
Genes are read by polymerases, which transcribe them into primary RNA transcripts 
(pre-mRNAs) with both the exons and introns of the genes retained.  The introns from 
the pre-mRNAs are then removed and the remaining exons are stitched together by 
spliceosomes to produce mature RNA transcripts (mRNAs).  During this splicing 
event, some of the exons can often be skipped, a process called alternative splicing, 
which produces different RNA transcripts and therefore adds more diversity to their 
final protein products.  From the experiment conducted by Wang et al. [4], most 
human genes (92~94%) are found to be alternatively spliced.  These mRNAs are 





translated into proteins by ribosomes.  These proteins cooperate with other proteins in 
a coordinated way to perform all the cell’s functions.  The rate of gene expression 
varies significantly in different types of cells.  The gene expression within an 
individual cell will change to meet the cell’s needs at any given time.  Thus, a further 
qualitative and quantitative understanding of this fundamental activity will provide 
invaluable insights into many biological functions.  One way we can pursue this with 
a high level of precision is by sequencing RNA molecules and employing 
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Figure 1.1 The path from DNA to proteins in eukaryotic cells 
The gene shown above includes four exons (e1, e2, e3, e4) separated by three introns.  First, 
the gene is transcribed into primary or precursor messenger RNAs (pre-mRNAs) in which all 
the exons and introns are retained.  Second, these pre-mRNAs are spliced into multiple 
mature RNA transcripts (mRNAs) in a way that all the introns are removed and some of the 
exons are selectively excluded.  Third, these mRNAs are transferred from the nucleus to the 
cytoplasm, where finally ribosomes bind to them and then translate them into proteins. 
 
 
One advantage of RNA-sequencing [5-8] is that, unlike microarray expression 
techniques [9, 10], it does not rely on pre-existing knowledge of gene content, and 
therefore it can detect entirely novel genes and novel splice variants of existing genes.  
Other applications of RNA-sequencing technologies include reconstruction and 
expression estimation of transcripts [11-13], differential expression analysis [14, 15], 
identification of transcript start site [16], discovery of fusion genes [17-19], and so 
on. 
Figure 1.2 (upper panel) shows a simplified form of RNA sequencing process 
showing how mRNAs are sequenced, producing a huge number of reads in a single 
run: tens of millions to hundreds of millions of reads whose read lengths range from 
50 to 400 base pair (bp).  The simplified steps of RNA-sequencing are described as 
follows. 
1. mRNAs are extracted from cells of interest. 
2. The mRNAs are reverse-transcribed into complementary DNAs (cDNAs). 
3. The cDNAs are sheared into smaller fragments, which in turn are size-
selected normally from 200 to 500 bp. 
4. The resulting fragments from the above step are sequenced from both 






Many vendors provide RNA-sequencing platforms, notably, Illumina 
(http://www.illumina.com), Roche 454 (http://www.454.com), and Life Technologies 
(http://www.lifetechnologies.com).   
 
Figure 1.2 Sequencing and reconstruction of mRNAs 
!"#$%&


















"(45& 67-*& 8*2'-*& 8*2(',(*1+&'(,1-*&


























The top panel shows sequencing steps, most of which are biochemical processes.  First, 
mRNAs are prepared from cells of interest.  Second, these fragments are reverse-transcribed 
into cDNAs, fragmented, and size-selected.  Third, these cDNAs are sequenced producing a 
huge amount of reads.  The bottom panel shows computational steps to reconstruct mRNAs 
from relatively short RNA-seq reads.  First, the reads are aligned against the reference 
genome to identify where they are likely to originate.  Second, the mapped positions of the 
reads are used to assemble mRNAs.  Details are given in the text. 
 
These RNA-seq reads can be used to reconstruct the full set of mRNA 
transcripts (isoforms) that were present in the original cells using bioinformatics 
approaches as illustrated in Figure 1.2 (lower panel). 
1. Reads are aligned against the reference genome, which provides 
information about their likely genes of origin.  A set of overlapping reads 
in terms of their mapped positions can be clustered into groups, each 
group presumably representing isoforms of the same gene. 
2. For each group of reads, a graph is built whose vertex vi represents a read 
and whose edge (vi, vj) represents “compatibility” relationship between 
two nodes vi and vi.  This graph can be compressed by combining vertices 
into “super” vertices without loss of generality, where the new vertices 
are equivalent to partial or full exons as shown in Figure 1.2 (lower 
panel). 
3.  A minimum set of paths covering the graph can be found using several 
approaches.  For instance, the assembly algorithm of Cufflinks first finds 
mutually incompatible vertices, suggesting there are at least that many 
different transcripts.  It can then reconstruct transcripts by finding paths 






1.2 Spliced alignment for RNA-seq reads 
 
Initially, RNA-seq reads are aligned against the reference genome.  The 
results provide the location from which the reads originated.  Assuming that 
sequencing reads are uniformly distributed along a transcript [21], we would expect 
33-38% of 100-bp reads from an RNA-seq experiment to span two or more exons.  
Note that this proportion increases significantly from 19 to 46% as read length 
increases from 50 to 150 bp (see Chapter 2 for more details).  Based on this 
observation, the alignment accuracy of those spliced reads can determine the accuracy 
of downstream steps of the analysis. 
This mapping problem for RNA-seq reads turns out to be more challenging 
compared to that of DNA-seq reads, posing two additional problems.  First, because 
genes in eukaryotic genomes contain introns and because reads sequenced from 
mature mRNA transcripts do not include these introns, any RNA-seq alignment 
program must be able to handle gapped alignment (or spliced alignment) with very 
large gaps.  In mammalian genomes, introns span a very wide range of lengths, 
typically from 50-100,000 bases, which the alignment algorithm must accommodate.  
Second, the presence of processed pseudogenes from which some or all introns have 
been removed may cause many exon-spanning reads to map incorrectly.  This 
problem is particularly acute in the case of genomes like the human genome, which 
contains over 14,000 pseudogenes [22]. 
In Chapter 2, we will discuss TopHat2, a new spliced aligner, in an attempt to 
handle these problems.  TopHat2 employs a two-step procedure similar to that of 





precision compared to the original algorithm of TopHat.  It then uses these candidate 
splice sites to align multi-exon spanning reads properly in a subsequent step.  In these 
steps, TopHat2 uses Bowtie as its underlying alignment program.  I implemented new 
procedures that align reads with true insertions and deletions (indels) – a feature 
critical for studies assessing the impact of genetic mutations on gene and transcript 
expression.  Indels due to sequencing errors will be discovered by TopHat2’s 
underlying mapping engine, Bowtie2 [24], which can detect short indels very 
efficiently.  The new algorithm also makes powerful use of available gene 
annotations, which prevents it from erroneously mapping reads to pseudogenes and 
improves its overall alignment accuracy.  Annotation also allows TopHat2 to better 
align reads that cover microexons, noncanonical splice sites, and other unusual 
features of eukaryotic transcriptomes.  These new enhancements will provide major 
accuracy improvements over previous versions and other RNA-seq mapping tools. 
Chapter 2 is based on the following work, which is under review. 
 
Daehwan Kim, Geo Pertea, Cole Trapnell, Harold Pimentel, Ryan Kelley, and Steven 
L. Salzberg 
TopHat2: Accurate alignment of transcriptomes in the presence of insertions, 
deletions, and gene fusions.  To appear in Genome Biology 
 
1.3 Discovery of fusion break points using RNA-seq reads 
 
In addition to detection of novel genes, RNA-seq has the potential to discover 





“fusion” genes formed by the breakage and re-joining of two different chromosomes 
have repeatedly been implicated in the development of cancer, notably the 
BCR/ABL1 gene fusion in chronic myeloid leukemia [17, 25, 26].  Fusion genes can 
also be created by the breakage and rearrangement of a single chromosome, bringing 
together transcribed sequences that are normally separate.  As of November 2012, the 
Mitelman database [27] has documented about 62,000 cases of chromosome 
aberrations and gene fusions in cancer.  1,078 gene fusions have been reported from 
1,309 different genes [28].  Most fusion genes are strongly associated with distinct 
cancerous tumor types, whereas some others are reported even in benign tumor cells 
or normal cells.  As well as from genomic aberrations described above, fusion events 
can take place during the transcription process in which two adjacent genes are 
transcribed as a single pre-RNA molecule, and then spliced into a fusion mRNA.  
Akiva et al. [29] performed a bioinformatics approach using expressed sequence tags 
(ESTs) and cDNAs downloaded from GenBank [30], showing that about 2% of the 
human genes are associated with such read-through transcription.  Fusion transcripts 
can also be formed post-transcriptionally when two different pre-RNA transcripts 
from two genes are spliced together and combined into one single mRNA transcript 






Figure 1.3 Several pathways leading to the formation of fusion transcripts 
 
Discovering these fusions via RNA-seq has a distinct advantage over whole-
genome sequencing.  This is due to the fact that in the highly rearranged genomes of 
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might alter transcription.  RNA-seq identifies only those chromosomal fusion events 
that produce transcripts.  It has the further advantage that it allows one to detect 
multiple alternative splice variants that might be produced by a fusion event. 
In Chapter 3, we will describe a fusion detection algorithm, TopHat-Fusion 
[19].  TopHat-Fusion directly detects individual reads and paired reads that span a 
fusion event.  Because it does not rely on annotation, TopHat-Fusion can also find 
events involving novel splice variants and entirely novel genes.  TopHat-Fusion’s 
performance was evaluated using RNA-seq reads from four breast cancer cell lines 
(BT474, SKBR3, KPL4, MCF7).  Edgren et al. [18] initially reported 24 novel and 3 
known fusion genes in this data sample.  Using TopHat-Fusion, 25 of the 27 fusion 
genes were retrieved, in addition to 51 strong candidates for novel fusion genes.  
Approximately one year later, Kangaspeska et al. [32] (including Edgren) 
experimentally verified 9 of those 51 candidates to be genuine fusion genes. 
Fusion-finding software currently faces serious problems, including very high 
false positive rates.  FusionSeq [33] and deFuse [34], found 32,644 and 1,670, 
respectively, for MCF7 cell lines, which harbor three known fusion genes.  Almost all 
of FusionSeq and deFuse’s findings are expected to be false positives.  In contrast to 
other fusion-finding software, TopHat-Fusion demonstrates highly accurate and 
sensitive discovery of fusion transcripts, having reported 3 known fusion genes and 
only 8 strong candidates. 
The following paper in Genome Biology is the basis for Chapter 3. 
 




TopHat-Fusion: An Algorithm for Discovery of Novel Fusion Transcripts.  Genome 
biology 2011, 12:R72. 
 
1.4 Reconstruction and quantitation of fusion transcripts 
As described in the above section, TopHat-Fusion aligns reads across fusion 
break points and reports the fusion alignments in Sequence Alignment/Map (SAM) 
format [35].  SAM has rapidly become the most popular format for representing read 
alignments.  Read alignments in the SAM format can be used for reconstruction and 
quantification of fusion transcripts as well as normal transcripts.  More specifically, 
based on the read alignments from TopHat-Fusion, those that are aligned near or 
across the break points can be assembled into fusion transcripts, and the expression 
levels of the transcripts can be quantified based on the number of reads they include. 
Two major factors make this problem more difficult: first, eukaryotic 
genomes are highly repetitive [36, 37], meaning the reads can align to many locations 
and second, sequencing errors (e.g., random ligation of two cDNAs) may cause 
chimeric transcripts.  The problem of separating genuine fusion transcripts from these 
spurious fusion-like transcripts, which are much more numerous than true fusions, is 
a major algorithmic challenge.  The problem is made harder by the fact that reads are 
non-uniformly distributed across transcripts, making low-level transcripts difficult to 
detect.  A sensitive and accurate method for identifying fusions should find as much 
evidence as possible that can be used as either positive or negative indicators when 




I have developed TransFUSE to address these problems.  TransFUSE is the 
software system designed to reconstruct and quantify full-length fusion gene 
transcripts.  The newly developed algorithm, using TopHat2 and Cufflinks, can be 
run with or without gene annotations.  As a result, it can detect novel fusion 
transcripts from known and unknown genes.  In Chapter 4, we will discuss more 
details about TransFUSE.  Chapter 4 is based on the following work, which is in 
preparation for submission. 
 
 
Daehwan Kim and Steven L. Salzberg 





RNA-seq technologies deliver a large amount of data within a short period of 
time (a few days) at much lower costs.  These benefits allow us to quickly and 
accurately investigate genetic programs and cellular activity.  Using these new 
sequencing technologies, we can examine transcript structures, expression levels of 
transcripts, and structural variations.  However, the sequencing technologies require 
new computational methods in order to effectively use a large amount of RNA-seq 
reads they produce. 
Most RNA-seq analyses rely on the genomic locations of reads’ origins.  In 
order to find the location information, reads may be aligned against the reference 




the reference and the sequenced genome is small, as is the case with the human 
genome.  Mapping accuracy and sensitivity of the alignment determine the quality of 
the downstream analyses.  A significant portion of this thesis is devoted to discussing 
effective solutions to RNA-seq read alignment problems.  As a solution, I have 
developed several novel algorithms and incorporated them into TopHat2, an RNA-
seq alignment system (Chapter 2).  In particular, I designed a new algorithm, in 
collaboration with Cole Trapnell, called “segment-search”, for identifying splice sites 
with high level of precision and sensitivity (see Chapter 2 for more details). I then 
implemented this method in the system.  I also designed a new algorithm that uses 
gene annotations to guide transcriptome mapping, a feature that was not part of 
TopHat before.  I collaborated with Harold Pimentel and Geo Pertea on this design, 
and they also collaborated on the implementation.  One problem I discovered in 
TopHat was that many reads may incorrectly map to processed pseudogenes during 
the first alignment stage (end-to-end genome alignment). In order to fix this mapping 
bias, I have came up with the idea of re-aligning many reads in a subsequent step.  I 
added this “realignment” option to TopHat2’s spliced alignment stage, and as a result 
most of the reads are now correctly aligned.  TopHat2 also includes a novel indel 
alignment algorithm, developed by Ryan Kelley and myself.  I made further 
adjustments to TopHat2 in order to support greater read lengths and to support 
“colorspace” reads from ABI SOLiD.  The colorspace method required substantial 
changes in many parts of TopHat2.  To improve TopHat2's performance, I have 
parallelized most of the steps in its pipeline.  Geo Pertea and I have changed TopHat2 




requirement. All these changes significantly improve the performance of TopHat2 
and contribute to the success of TopHat2 in the research community. 
RNA-seq also enables us to discover structural variations, including genomic 
rearrangements.  I have developed TopHat-Fusion to detect fusion break points and 
map reads against them (Chapter 3).  In TopHat-Fusion, I have developed novel 
algorithms for finding fusion break points and align reads across the break points.  I 
have also created sophisticated filtering algorithms to eliminate false fusion 
transcripts.  This filtration is based on several factors such as supporting reads and 
pairs, sequence similarity, and transcript coverage.  TopHat-Fusion’s advanced fusion 
alignment algorithm combined with the filtration step enables efficient and sensitive 
discovery of fusion transcripts.  Furthermore, I have enhanced and modified TopHat-
Fusion to allow the assembly and quantification of fusion transcripts.  The enhanced 
pipeline is TransFUSE (Chapter 4).  The new assembly and quantification algorithms 
of TransFUSE are based on Cufflinks, where I have modified almost every aspect of 
the system in addition to creating a novel algorithm to filter out false fusion 
transcripts.  The new information available from these new algorithms such as 
transcript structures and expression levels is used to identify genuine fusion 
transcripts.  I have developed a visualization algorithm to display fusion transcripts in 
html format, which makes it easier to investigate and directly compare fusion 
transcripts. 
However, our software system faces several issues as the sequencing 




several related problems that demand some fundamental changes in our pipeline, as 






Chapter 2: TopHat2: accurate alignment of transcriptomes in the 
presence of insertions, deletions and gene fusions 
 
Since the initial release of TopHat [23], a spliced aligner for sequences from 
transcriptome sequencing (RNA-seq) experiments, I have made many significant 
enhancements to the program, contributing to improvements in the quality of 
downstream analysis.  The new TopHat2 program can align reads of various lengths 
produced by the latest sequencing technologies, including Illumina, 454 
pyrosequencing, and ABI “colorspace” reads, while allowing for variable-length 
insertions and deletions with respect to the reference genome.  In addition to its de 
novo splice junction mapping algorithm, TopHat2 incorporates an algorithm to align 
reads across fusion break points, which occur after genomic translocations or trans-
splicing (see Chapter 3 for more details).  The new system combines the ability to 
discover novel splice sites with direct mapping to known transcripts, producing more 
sensitive and accurate alignments than previously, even for highly repetitive genomes 
or in the presence of processed pseudogenes.  A new re-alignment procedure 
substantially reduces mis-alignments caused by reads that extend only a few bases 
into an intronic region.  Finally, in order to keep up with dramatically increasing 
sequencing rates, the TopHat2 algorithm includes new parallel code and other 




TopHat2 is free, open-source software available from 
http://genomics.jhu.edu/software/tophat.   
 
2.1 Background 
RNA sequencing technologies [5-7], which sequence the RNA molecules 
being transcribed in cells, allow us to explore the process of transcription in exquisite 
detail.  One of the primary goals of RNA sequencing analysis software is to 
reconstruct the full set of transcripts (isoforms) of genes that were present in the 
original cells.  In addition to the transcript structures, experimenters need to estimate 
the expression levels for all transcripts.  The first step in the analysis process is to 
map the RNA-seq reads against the reference genome, which provides the location 
from which the reads originated.  In contrast to DNA sequence alignment, RNA-seq 
mapping algorithms have two additional challenges.  First, because genes in 
eukaryotic genomes contain introns and because reads sequenced from mature mRNA 
transcripts do not include these introns, any RNA-seq alignment program must be 
able to handle gapped alignment (or spliced alignment) with very large gaps.  In 
mammalian genomes, introns span a very wide range of lengths, typically from 50-
100,000 bases, which the alignment algorithm must accommodate.  Second, the 
presence of processed pseudogenes from which some or all introns have been 
removed may cause many exon-spanning reads to map incorrectly.  This probably is 





In the most recent Ensembl GRCh37 gene annotations, the average length of a 
mature mRNA transcript in the human genome is 2,227 bp, and the average exon 
length is 235 bp.  The average number of exons per transcript is 9.5.  Assuming that 
sequencing reads are uniformly distributed along a transcript [21], we would expect 
33-38% of 100-bp reads from an RNA-seq experiment to span two or more exons.  
Note that this proportion increases significantly as read length increases from 50 to 
150 bp (see Supplementary Material for more details). 
More importantly for the alignment problem, ~20% of junction-spanning 
reads extend 10 bp or less into one of the exons they span.  These small “anchors” 
make it extremely difficult for alignment software to map reads accurately, 
particularly if the algorithm relies (as most do) on an initial mapping of fixed-length 
k-mers to the genome.  This initial mapping, using exact matches of k-mers, is critical 
for narrowing down the search space into small local regions where a read is likely to 
align.  If a read only extends a few bases into one of two adjacent exons, then it often 
happens that the read will align equally well, but incorrectly, with the sequence of the 
intervening intron.  For example, as illustrated in Figure 2.1, suppose that read r spans 
exons e1 and e2, extending only 4 bases into e2.  Suppose also that that e2 begins with 
GTXX, and the intervening intron also begins with GTXX.  Then r might align 
perfectly to e1 and the first 4 bases of the intron, and the alignment algorithm will fail 
to find the spliced alignment of r. 
In order to handle this problem, TopHat2 uses a two-step procedure.  First, 
similar to TopHat1 [23], it detects potential splice sites for introns (detailed further in 




properly in a subsequent step.  Some RNA-seq aligners, including GSNAP [38], 
RUM [39], and STAR [40], map reads independently of the alignments of other 
reads, which may explain their lower sensitivity for these spliced reads (see Results).  
MapSplice [41] uses a two-step approach similar to TopHat2. 
RNA-seq read alignment is further complicated due to the presence of 
processed pseudogenes in the reference genome.  Pseudogenes often have highly 
similar sequences to functional, intron-containing genes, and in most cases the 
pseudogene versions are not transcribed [42], though this has recently been disputed 
[43].  The critical problem for alignment is that reads spanning multiple exons can be 
mapped perfectly or near-perfectly to the pseudogene version of a functional gene.  
For example, suppose a read r spans two exons of a given gene.  If the aligner tries to 
align the read globally (end-to-end), then it will find an alignment to the pseudogene 
copy (Figure 2.1).  If the spliced alignment phase, which usually occurs later, does 
not attempt to re-align r, then the pseudogene copy will “absorb” all reads spanning 
splice sites for that gene.  TopHat2 can feed r into the spliced alignment phase even 
when r has been aligned end-to-end, allowing it to circumvent this problem (see 





Figure 2.1 Two possible incorrect alignments of spliced reads 
(1) A read extending a few bases into the flanking exon can be aligned to the intron instead of 
the exon.  (2) A read spanning multiple exons from genes with processed pseudogene copies 
can be aligned to the pseudogene copies instead of the gene from which it originates. 
 
We also note as an aside that, in our analysis of RNA-seq reads from multiple 
human samples [44, 45], genes with processed pseudogenes seem to be expressed at 
higher levels than other genes (see Results).  Although this observation has not been 
explored thoroughly, a plausible explanation is that genes with higher levels of 
expression may, over the course of evolution, have an increased chance of being 
picked up by transposons and re-integrated into the genome, creating pseudogene 
copies. 
For the human genome, where we have relatively comprehensive annotations 
























aligning reads preferentially to real genes rather than pseudogenes. GSNAP [38] and 
STAR [40] also make use of annotation, although they use it in a more limited 
fashion to detect splice sites.  TopHat2 can use the full-length transcripts defined by 
annotations during its initial mapping phase, which produces significant gains in 
sensitivity and accuracy (see Figures 2.3 - 2.6). 
Transcripts from a target genome may differ substantially from the reference 
genome, possibly containing insertions, deletions, and other structural variations [46, 
47].  For such regions, previous spliced alignment programs (including the original 
TopHat) sometimes fail to find a proper alignment.  In TopHat2, I implemented new 
procedures that align reads with true insertions and deletions (indels).  Indels due to 
sequencing errors will be discovered by TopHat2’s underlying mapping engine, 
Bowtie2 [24], which can detect short indels very efficiently.  Very large deletions, 
inversions on the same chromosome, and translocations involving different 
chromosomes are detected by the TopHat-Fusion algorithms [19], which are now 
incorporated into TopHat2 and available by a simple command-line switch. 
TopHat2 also includes new algorithms to handle more diverse types of 
sequencing data.  This includes the ability to handle reads generated by ABI SOLiD 
technology using its “color space” representation.  To accomplish this, TopHat2 uses 
a reference genome translated entirely into color space in order to take advantage of 
the error-correction capability of that format.  TopHat2 also handles data sets in 
which the reads have variable lengths, allowing the experimenter to merge data sets 





Given RNA-seq reads as input, TopHat2 begins by mapping reads against the 
known transcriptome, if an annotation file is provided.  This transcriptome mapping 
improves overall mapping sensitivity and accuracy.  It also gives a significant speed 
boost, owing to the much smaller size of the transcriptome compared to that of the 
genome (see Figure 2.2). 
 
Figure 2.2 TopHat2 pipeline 























































































After the transcriptome mapping step, some reads remain unmapped because 
they are derived from unknown transcripts not present in the annotation, or because 
they contain many mis-called bases.  In addition, there may be poorly aligned reads 
that have been mapped to the wrong location.  In step 2, TopHat2 aligns these 
unmapped or potentially mis-aligned reads against the genome (Figure 2.2).  Any 
reads contained entirely within exons will be mapped, whereas others spanning 
introns may not be. 
Using unmapped reads from step 2, TopHat2 tries to find novel splice sites 
that are based on known junction signals (GT-AG, GC-AG, and AT-AC).  TopHat2 
also provides an option to allow users to remap some of the mapped reads depending 
on their edit distance values, that is, those reads whose edit distance is greater than or 
equal to a user-provided threshold will be treated as unmapped reads.  To accomplish 
this, the unmapped reads (and previously mapped reads with low alignment scores) 
are split into smaller non-overlapping segments (25-bp each by default) which are 
then aligned against the genome (Figure 2.2, step 3).  Tophat2 examines the cases 
where the left and right segments of the same read are mapped within a user-defined 
maximum intron size (usually between 50 and 100,000 bp).  When this pattern is 
detected, TopHat2 re-aligns the whole read sequence to that genomic region in order 
to identify the most likely locations of the splice sites, as shown in Figure 2.2.  Indels 
and fusion break points are also detected in this step using a similar approach. 
The genomic sequences flanking these splice sites are concatenated and the 




Any reads not mapped in the previous stages (or mapped very poorly) are then re-
aligned with Bowtie2 [24] against this novel transcriptome. 
After these steps, some of the reads may have been aligned incorrectly by 
extending an exonic alignment a few bases into the adjacent intron (see Figure 2.1 
and Figure 2.2, step 3-5). TopHat2 checks if such alignments extend into the introns 
identified in the split alignment phase, and if so, it can re-align these reads to the 
adjacent exons instead. 
In the final stage, TopHat2 divides reads into those with unique alignments 
and those with multiple alignments.  For the multi-mapped reads, TopHat2 gathers 
statistical information (e.g., the number of supporting reads) about the relevant splice 
junctions, insertions, and deletions, which it uses to recalculate the alignment score 
for each read.  Based on these new alignment scores, TopHat2 reports the most likely 
alignment locations for such multi-mapped reads. 
For paired-end reads, TopHat2 processes the two reads separately through the 
same mapping stages described above.  In the final stage, the independently aligned 
reads are analyzed together to produce paired alignments, taking into consideration 
additional factors including fragment length and orientation. 
For the experiments described in this study, the program version numbers 
were TopHat2 (2.0.8), TopHat1 (1.1.4), GSNAP (2013-01-23), RUM (1.12_01), 
MapSplice (1.15.2), and STAR (2.3.0e).  Specific parameters for each program are 






TopHat2 can use either Bowtie [48] or Bowtie2 [24] as its core read alignment 
engine.  TopHat2 has its own indel-finding algorithm, which enhances Bowtie2’s 
indel-finding ability in the context of spliced alignments.  In order to evaluate 
TopHat2 and compare it other methods, we ran multiple computational experiments 
using both real and simulated RNA-seq data. 
For the simulations, we created multiple sets of 40,000,000 paired-end reads, 
100 bp in length, from the entire human genome (release GRCh37).  Instead of trying 
to precisely mimic real RNA-seq experiments, which may not be possible in any 
practical sense, we generated data with relatively simple settings and expression 
levels calculated using a model from the Flux Simulator system [49], as follows.  For 
the first test set, we generated reads from the known transcripts on the entire human 
genome without introducing any mismatches or indels.  We then generated additional 
data sets where we included (a) insertions and deletions into the known transcripts at 
random locations; and (b) insertions and deletions in the reads themselves to mimic 
sequencing errors (see Supplementary Material for details). 
Each of these types of experimental error was introduced to test different 
capabilities of TopHat2 and other RNA-seq aligners.  Following the simulations, we 
evaluated the programs using a recent, real RNA-seq data set.   
Alignment of simulated reads (error-free) 
 
We generated 40,000,000 paired-end reads and performed two sets of 




Table 2.1; and (2) using 20,000,000 pairs of reads, shown in Table 2.2.  Reads that 
span multiple exons are called junction reads; our single-end data contain 6,862,278 
such reads (34.3%).  The most challenging alignments are those for which a junction 
read extends 10 bp or less into one of the exons, which we call short-anchored reads; 
1,448,022 of the single-end reads (7.2%) fell into this category.  We report accuracy 





















+Bowtie1	   19,826,638	   98.31	   0.82	   0.87	   95.28	   93.69	  
TopHat2	  
+Bowtie2	   19,826,673	   98.03	   1.10	   0.87	   94.28	   89.67	  
TopHat1.14	   19,616,874	   94.64	   3.45	   1.91	   84.44	   44.08	  
GSNAP	   19,997,255	   94.21	   5.77	   0.02	   83.15	   26.01	  
RUM	   19,555,823	   88.11	   9.67	   2.22	   65.35	   8.59	  
MapSplice	   19,872,372	   97.28	   2.08	   0.64	   92.09	   75.57	  
STAR	   19,087,508	   92.14	   3.30	   4.56	   77.17	   3.54	  
Table 2.1 Performance comparisons on 20 million 100 bp single-end reads 
These reads are simulated based on transcripts from the entire human genome.  6,862,278 
reads span one or more splice junctions; the alignment accuracy of junction reads refers to 
this set.  1,448,022 reads extend 10 bp or less into one exon; the alignment accuracy of short-
anchored reads is based on these alignments. The last two columns show alignment accuracy 
for these subsets of the data. 
 
We also tested 20,000,000 read pairs (40,000,000 reads), of which 9,491,394 
(47.5%) have at least one read that spans multiple exons.  2,702,624 of these pairs 
(13.5%) have at least one short-anchored read that extends 10 bp or less into one of 



























+Bowtie2	   19,686,006	   96.19	   2.24	   1.57	   92.03	   85.88	  
TopHat1.14	   19,219,055	   89.57	   6.53	   3.90	   78.36	   40.39	  
GSNAP	   19,999,867	   88.84	   11.16	   0.00	   76.55	   22.87	  
RUM	   19,869,579	   79.07	   20.28	   0.65	   56.28	   8.42	  
MapSplice	   19,342,087	   92.03	   4.68	   3.29	   86.53	   72.48	  
STAR	   19,951,620	   85.21	   14.55	   0.24	   68.94	   3.16	  
 
Table 2.2 Performance comparisons on 20 million pairs of 100 bp reads 
These paired reads are simulated based on transcripts from the entire human genome.  
9,491,394 pairs of reads are junction pairs, and 2,702,624 pairs contain short-anchored reads.  
The last two columns show alignment accuracy for these subsets of the data. 
As shown in Table 2.1, TopHat2 correctly aligns >98% of the reads, more 
than any of the other methods, whose accuracy ranged from 88–97%.  The difference 
is more pronounced for junction reads, where TopHat2 is able to align >94% while 
other methods range in accuracy from 65–92%. 
GSNAP, RUM, and STAR have particular difficulty aligning short-anchored 
reads, only aligning 26%, 8.6%, and 3.5%, respectively.  MapSplice does 
considerably better, aligning 75.6% of these reads.  By contrast, TopHat2 aligns 
93.7% of the short-anchored reads using Bowtie1 as its main aligner (Table 2.1).  
Both TopHat2 and MapSplice use a two-step algorithm, first detecting potential splice 
sites, and then using these sites to map reads.  This two-step method may explain 
their superior performance at mapping reads with short anchors. 
The results for paired reads (Table 2.2) are similar to those for unpaired reads.  
TopHat2 aligns the highest percentage of reads, 96.7%, followed by MapSplice 
(92%) and the other methods (79-88%).  The difference widens again for junction 
reads, with TopHat2 at 93% followed by MapSplice (86%), GSNAP (76%), STAR 
(69%), and RUM (56%).  Most striking of all was the performance on short-anchored 




aligned 90% of these, MapSplice aligned 72%, and the other methods aligned only 3–
22%. 
Figure 2.9 shows alignment rates for reads, spliced reads, and spliced reads 
with small anchors for a variety of read lengths (50 bp, 100 bp, 150 bp, 200 bp).  
TopHat2 consistently outperformed all the other aligners for each read length.  In 
Tables 2.6 – 2.9, we compare alignment performance for spliced reads and pairs with 
a 1-3 mismatches, where TopHat2 and MapSplice show the highest recall rates.  
 
Alignment of simulated reads with short indels (1-3bp) 
 
Next we tested the spliced alignment programs using reads with small indels, 
using two sets of simulated reads: (1) true indels, in which the transcripts were 
modified by inserting or deleting 1-3 bases at random locations; and (2) indels due to 
sequencing errors, in which indels are randomly inserted into the reads.  As before, 
all transcripts were simulated from known genes from the entire human genome.  We 
used a relatively high rate of indels intentionally, to test the mapping capabilities of 
the programs in the presence of these types of mutations.   
Tables 2.3-2.4 shows the results for these data sets.  For single-end reads, 
RUM, GSNAP, and TopHat2 perform similarly, with 69-82% accuracy (recall) rates 
for true indels and 62-83% for reads with indel sequencing errors.  STAR and 
MapSplice show relatively lower recall rates for both data sets.  Note that when used 
with the original Bowtie program (a non-gapped aligner), TopHat2 is able to map 







Reads	  with	  true	  indels	  
(1,428,499)	  













+Bowtie1	   70.9	   16.8	   12.1	   2.8	  
TopHat2	  
+Bowtie2	   63.7	   25.2	   62.6	   21.2	  
GSNAP	   82.7	   71.9	   83.1	   71.8	  
RUM	   69.4	   43.0	   70.3	   45.4	  
MapSplice	   27.3	   3.7	   27.5	   3.8	  
STAR	   46.6	   16.9	   47.7	   17.1	  
Table 2.3 Performance comparisons on single-end reads containing indels 
The indels are 1-3bp.  The number of reads containing each type of error is indicated in the 
column header.  Boundary indels occur within 25 bp of an exon boundary.  Percentages refer 
only to the reads of each type, not to the entire data set. 
 
Program	  
Pairs	  with	  true	  indels	  
(2,754,313)	  













+Bowtie1	   69.8	   16.3	   14.0	   3.1	  
TopHat2	  
+Bowtie2	   62.3	   24.0	   60.8	   19.8	  
GSNAP	   77.0	   63.8	   77.8	   64.8	  
RUM	   60.3	   34.3	   61.3	   36.0	  
MapSplice	   25.5	   3.4	   25.0	   3.2	  
STAR	   53.4	   19.2	   54.9	   21.4	  
Table 2.4 Performance comparisons on paired reads containing indels 
The indels are 1-3bp.  The number of pairs containing each type of error is indicated in the 
column header.  Boundary indels occur within 25 bp of an exon boundary.  Percentages refer 
only to the pairs of each type, not to the entire data set. 
 
For paired-end reads with indels, GSNAP has the highest rate of correct 
alignments (77%), followed by TopHat2 (60-69%), RUM (60-61%), and STAR (53-





We defined boundary indels as those within 25 bp of a splice site.  We 
separately computed the accuracy on reads with boundary indels, shown in Tables 
2.3-2.4.  
 
Alignment of a large set of real RNA-seq reads 
 
Any test of alignment algorithms should use real data to provide a measure of 
likely performance in practice.  For these experiments, we used a recently released set 
of RNA-seq reads gathered across a time course experiment reported by Chen et al. 
[44] (GEO accession number GSM818582).  This data includes 130,705,578 million 
paired-end reads in 65,352,789 pairs.  All reads are 101 bp in length. 
Because we do not know the true alignments for this RNA-seq data set, we 
used the following objective criteria to evaluate each program: 
1. The cumulative number of alignments with edit distances of 0, 1, 2, and 3 for 
each read. 
2. The cumulative number of spliced alignments that agree with the annotation 
for the corresponding human genes, taken from the Ensembl GRCh37 release 
of the human genome. 
For each program, we aligned the paired-end reads with and without the 
known gene annotations, where possible.  RUM requires annotations and cannot be 
run without them, while MapSplice maps strictly without them.  We then evaluated 
the mapping results in terms of the number of read or paired-read mappings. 
TopHat2 consists of three mapping steps: (1) transcriptome mapping, used 




Methods for details).  TopHat2 uses a remapping edit distance threshold t, specified 
by the user, as follows.  If a read aligns to the transcriptome in step (1) with an edit 
distance less than t, TopHat2 will not remap the read in subsequent steps.  Otherwise, 
TopHat2 will try to re-align the read in steps (2) and (3), and then depending on the 
resulting edit distance, it will use the read to detect novel splice sites.  A setting of t=0 
means that TopHat2 will re-align every read in all three steps.  When we used t=0 
(“TopHat2 realignment 0” in Figure 2.3) on the real data, we consistently obtained 
better mapping results in terms of edit distance and the number of alignments that 
correspond to known splice sites, as shown in Figures 2.3-2.6 for read and pair 






Figure 2.3 The number of read alignments  
TopHat2, GSNAP, RUM, MapSplice, STAR are tested for the RNA-seq reads are from Chen 
et al. [44].  TopHat2 was run without realignment and with realignment (realignment edit 
distance of 0).  TopHat2, GSNAP, and STAR were run in both de novo and gene mapping 
modes, while MapSplice and RUM were run only in de novo and gene mapping modes, 










































































number of alignments at edit distance of 2 includes all the alignments with edit distance of 0, 
1, 2. 
 
Figure 2.3 shows the alignment performance for each program both with and 
without using annotations, where all the programs were configured to report 
alignments with edit distances of up to 3 (and more in some programs).  We 
compared the de novo alignments of reads for edit distances of 0, 1, 2, and 3.  As 
expected, all programs find more alignments as the maximum permissible edit 
distance increases.  For edit distance 0 (which only allows perfect matches), TopHat2 
without its new realignment function maps noticeably fewer reads than it does with 
the function.  This occurs because TopHat2 first aligns reads end-to-end (with 
Bowtie2) before trying spliced alignments.  Thus if a read is aligned end-to-end with, 
for example, 1-3 mismatches, then without the realignment function, TopHat2 accepts 
that alignment and may miss a spliced alignment with fewer mismatches. 
On the other hand, TopHat2 with t=0 mapped the largest number of reads for 
all edit distances, followed in most cases by GSNAP.  Note that for alignments with 
an edit distance up to 3, TopHat2 without realignment discovered almost as many 
alignments as GSNAP. 
When alignment methods are run with the assistance of gene annotations 
(Figure 2.3, right panel), the results are somewhat better than the de novo alignments.  
TopHat2 with or without realignment produced the highest number of mappings, 
followed by GSNAP, RUM, and STAR.  The realignment procedure gives a much 
small advantage to TopHat2 in these experiments. 
One way to estimate the accuracy of mappings is to compare alignments to 




splitting, counting how many known (Figure 2.4, left) and known plus novel (Figure 
2.4, right) splice sites they identified.  For de novo alignment, TopHat2 with 
realignment has the highest sensitivity, followed by MapSplice.  Consistent with our 
tests on simulated reads, GSNAP and STAR show relatively lower alignment rates.  
When using annotation, TopHat2 without realignment shows the highest mapping 
rate, slightly outperforming TopHat2 with realignment.  GSNAP and STAR, which 
do less well, map reads against substrings containing splice sites rather than whole 
transcripts.  Direct mapping against whole transcripts, as done by TopHat2, works 
well especially when mapping reads spanning small exons, where a single read might 





Figure 2.4 The number of spliced read alignments 
TopHat2, GSNAP, RUM, MapSplice, STAR are tested for the RNA-seq reads are from Chen 
et al. [44].  TopHat2, GSNAP, and STAR were run in both de novo and gene mapping modes.  
MapSplice and RUM were run in gene and de novo mapping modes, respectively.  For each 

















































































De novo alignment (all)

































are found in the gene annotations and the right two panels show the number of all spliced 
alignments including novel splice sites. 
 
Based on these results, we would suggest two alternative strategies for 
alignment with TopHat2.  First, if gene annotations are available, as they are for the 
human genome and some model organisms, then these annotations should be used 
with TopHat2, even without realignment.  Alternatively, if annotations are 
unavailable or incomplete, then we recommend using TopHat2 with its realignment 
algorithm to produce the most complete set of alignments. 
The runtime and the peak memory usage varied greatly among the programs 
used in this study. We compared performance on all programs using the Chen et al. 
data [44], 130 million reads, and results are shown in Table 2.15.  Overall, STAR is 
much faster (32 minutes) than the other programs, which required from 8 to 55 hours.  
However, STAR requires a large amount of real memory, at least 28 GB, while most 





Figure 2.5 The number of pair alignments 
TopHat2, GSNAP, RUM, MapSplice, STAR are tested for the RNA-seq reads are from Chen 






































































Figure 2.6 The number of spliced pair alignments 
TopHat2, GSNAP, RUM, MapSplice, STAR are tested for the RNA-seq reads are from Chen 


















































































































The impact of pseudogenes on RNA-seq mapping 
 
The Ensembl gene annotations (release 66) contain 32,439 genes, including 
non-coding RNA genes, and over 14,000 pseudogenes.  Of the real genes, we found 
that 872 (2.7%) genes have pseudogene copies; i.e., at least one transcript (or 
isoform) can be aligned to a pseudogene with at least 80% identity across the full 
length of the transcript.  Using data from the Chen et al. study [44] and from the 
Illumina Body Map project [45], we found that genes with pseudogene copies appear 
to have higher expression levels than those without pseudogene copies.  Table 2.5 
shows what proportion of reads map to genes with pseudogenes, using both the raw 
count and a normalized count divided by the length of the transcript.  Although only 
2.7% of genes have pseudogene copies, these genes account for 22.5% (un-
normalized) or 26.9% (normalized) of the RNA-seq reads in the Chen et al. data.  In 
the RNA-seq experiments from the Illumina Body Map (the white blood sample 
only), we see a 19.1% (normalized) of reads mapping to genes with pseudogenes 
(Table 2.17).  From both RNA-seq experiments, we note that genes with multiple 
pseudogene copies are more abundantly expressed than those with a single 
pseudogene copy.  We ran a similar analysis looking only at the 20,417 protein-
coding genes in Ensembl, with similar results:  22% of read pairs, 26 times more than 












1	   553	  (1.7%)	   6.85	   x	  4.02	   9.37	   x	  5.49	  
2	   113	  (0.4%)	   5.15	   x	  14.79	   5.20	   x	  14.93	  




4	   27	  (0.1%)	   2.27	   x	  27.32	   2.28	   x	  27.35	  
≥5	   130	  (0.4%)	   6.91	   x	  17.24	   8.08	   x	  20.16	  
Total	  (≥1)	 872/32,439	  (2.7%)	   22.45	   x	  8.35	   26.88	   x	  10.00	  
Table 2.5 The expression levels of genes with pseudogene copies 
Using Bowtie2, we aligned RNA-seq paired-end reads (Chen et al. [44]) to 32,439 annotated 
genes.  The first column shows the number of pseudogene copies a gene has.  The first row 
shows genes that have just one pseudogene, followed by rows for genes with 2, 3, 4, and at 
least 5 pseudogene copies.  Column 2 (“Gene with pseudogene”) is the number of genes with 
the specified number of pseudogene copies; e.g., 553 genes (1.7% of all genes) have one 
pseudogene copy.  Column 3 shows the percentage of read pairs that were mapped to genes 
with pseudogene copies.  Column 4 contains the ratio of columns 3 and 2.  The last two 
columns are similarly defined using a normalized count, where the number of reads mapping 
to each gene was normalized to account for gene length. 
Figure 2.7 shows various mapping results from TopHat2 with and without 
realignments at various edit distances.  As we allow TopHat2 to realign more reads, it 
finds the spliced alignments that were otherwise hidden by pseudogene alignments.  





Figure 2.7 The number of read and spliced read alignments 
TopHat2 is run using different realignment edit distances of 0, 1, 2 and no-realignment.  As 
TopHat2 allows more realignment from no-realignment to 2 to 1 to 0, the number of read 
alignments and spliced read alignments increases, where the differences in the numbers of 
read alignments from TopHat run with different realignment edit distance are mostly 












































 Spliced read alignment






The differences in the numbers of alignments at edit distance of 0 are 
 mostly explained by the differences in the numbers of spliced alignments at edit distance of 0





The completeness of human gene annotations 
 
Using the de novo mapping mode in TopHat2, GSNAP, MapSplice, and 
STAR, we looked at how many spliced alignments are found in the Ensembl 
annotations.  As shown in Figure 2.8, the proportions of spliced mappings to known 
splice sites are 97%, 96%, 88-90%, and 83-93% in GSNAP, STAR, TopHat2, and 
MapSplice, respectively.  Although our analysis only considered RNA-seq data from 
Chen et al. [44], the TopHat2 result suggests that many additional spliced alignments, 
up to 12%, might remain to be discovered.  Most of the novel splicing events in these 






Figure 2.8 The number of spliced read alignments 
TopHat2, GSNAP, STAR, and MapSplice are tested without using gene 
annotation for  
The number of read alignments whose splice sites are found in the gene annotations are 
shown in brown color.  The number of all spliced read alignments including novel splice sites 
are shown in green color. 
 
2.4 Conclusions 
Discovery of new genes and transcripts is a major objective in many RNA-seq 
experiments.  Deep RNA-seq experiments continue to uncover previously unseen 




































































genome is a core step in such screens, and the accuracy of mapping software can 
determine the accuracy of downstream steps such as gene and transcript discovery or 
expression quantitation. 
I have described TopHat2, which provides major accuracy improvements over 
previous versions and other RNA-seq mapping tools.  Because TopHat2 is built 
around Bowtie2, it can now align reads across small indels with high accuracy – a 
feature critical for studies assessing the impact of genetic mutations on gene and 
transcript expression.  I have engineered TopHat2 to work well with a wide range of 
RNA-seq experimental designs, and it is optimized for the widely available long, 
paired-end reads.  These reads pose new challenges because they can span multiple 
splice sites rather than just one or two – we estimate that nearly half of reads 150-bp 
long would span more than two human exons.  The algorithmic improvements in 
TopHat2 address this challenge, maintaining both accuracy and speed.  Other 
refinements to the algorithm increase accuracy for reads that span a junction with 
only a small (≤10 bp) overhang, reducing errors in downstream transcript assembly 
using tools such as Cufflinks.  TopHat2 also makes powerful use of available gene 
annotations, which allow it to avoid erroneously mapping reads to pseudogenes and 
generally improve its overall alignment accuracy.  Annotation also allows TopHat2 to 
better align reads that cover microexons, noncanonical splice sites, and other 
“unusual” features of eukaryotic transcriptomes. 
TopHat2 has proved to perform well over a wide range of read lengths, 
making it a good fit for most RNA-seq experimental designs.  This scalability 




alignment results and allow for robust downstream analysis.  We argue that TopHat2 
reports more accurate alignments than competing tools using fewer computational 
resources.  RNA-seq experiments are becoming increasingly common and are now 
routinely used by many biologists.  We expect that TopHat2 will provide these 
scientists with accurate results for use with expression analysis, gene discovery, and 
many other applications. 
2.5 Supplementary Material 
Alignments of simulated reads with up to 3 mismatches 
We generated single-end and paired-end reads with 0 to 3 mismatches and 
without indels as shown in Tables 2.6 and 2.8.  TopHat2 and MapSplice show the 
highest mapping sensitivity in read/pair and spliced read/pair alignments for both true 
mismatches (SNPs) and sequencing-error mismatches (Tables 2.7 and 2.9). 
Type	   No.	  of	  total	  reads	  




































Table 2.6 The number of reads and spliced reads with up to 3 mismatches 
Program	   True	  mismatches	   Sequencing-­‐error	  mismatches	  
M0	   M1	   M2	   M3	   J0	   J1	   J2	   J3	   M0	   M1	   M2	   M3	   J0	   J1	   J2	   J3	  
TopHat2	  
+Bowtie1	   98.14	   98.71	   98.83	   97.57	   95.81	   95.86	   96.45	   91.52	   98.37	   98.60	   98.79	   97.19	   95.67	   96.23	   96.71	   92.23	  
TopHat2	  
+Bowtie2	  
97.85	   98.70	   95.08	   86.72	   95.00	   95.75	   84.59	   55.21	   98.08	   98.54	   93.87	   84.98	   94.61	   95.95	   83.16	   58.69	  
GSNAP	   92.85	   89.08	   83.50	   78.33	   83.33	   77.49	   74.19	   70.27	   93.95	   88.19	   83.09	   77.66	   83.03	   77.61	   74.29	   69.35	  
RUM	   85.10	   83.45	   77.58	   73.82	   65.25	   54.29	   45.82	   37.93	   87.58	   81.43	   75.37	   69.57	   65.13	   55.16	   45.55	   36.63	  
MapSplice	   96.77	   98.25	   97.96	   93.94	   92.47	   94.25	   96.98	   96.95	   96.85	   97.77	   97.78	   94.63	   91.16	   93.79	   95.94	   95.82	  




Table 2.7 The recall rates of read and spliced read alignments for true 
mismatches (SNPs) and sequencing-error mismatches 
M0 is the sensitivity of read alignments with zero mismatches.  M1 is the sensitivity of 
alignments with one mismatch.  M2 and M3 are similarly defined.  J0 is the sensitivity of 
spliced alignments with no mismatches.  J1, J2, and J3 are similarly defined with mismatches 
of 1, 2, and 3, respectively, for spliced alignments.  M0, M1, M2, and M3 also include spliced 
alignments as well as non-gapped alignments.  Note that TopHat2 with Bowtie2 suffers a 
drop in performance compared to Bowtie1 when a single read has 3 mismatches (column J3).  
This occurs because TopHat2 splits reads into very short segments, 25 bp, when attempting to 
align across splice sites.  TopHat2 then calls Bowtie1/2 to align these short segments.  
Bowtie2’s default parameters are not designed for such short segments; however these can 
easily be modified by changing the parameters used to call Bowtie2 within TopHat2. 
 
Type	   No.	  of	  total	  pairs	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  pairs	  























Table 2.8 The number of pairs and spliced pairs with mismatches of 0 to 3 
The two types of pair reads are simulated: true mismatches (SNPs) and sequencing-error 
mismatches.  Note that each read can contain up to 3 mismatches, it is possible that a pair can 
have more than 3 mismatches. 
 
 
Program	   True	  mismatches	   Sequencing-­‐error	  mismatches	  
M0	   M1	   M2	   M≥3	   J0	   J1	   J2	   J≥3	   M0	   M1	   M2	   M≥3	   J0	   J1	   J2	   J≥3	  
TopHat2	  
+Bowtie1	   95.69	   96.96	   97.47	   97.45	   93.03	   93.14	   93.64	   93.12	   96.72	   96.98	   97.19	   96.91	   93.19	   93.78	   94.15	   93.51	  
TopHat2	  
+Bowtie2	  
95.06	   96.77	   96.01	   91.94	   91.90	   92.52	   89.40	   78.18	   96.10	   96.59	   94.92	   89.86	   91.46	   92.60	   89.33	   78.12	  
GSNAP	   84.03	   83.95	   79.29	   72.72	   74.03	   69.83	   64.84	   58.95	   88.34	   83.20	   77.52	   70.99	   73.84	   69.76	   64.84	   59.17	  
RUM	   69.86	   73.97	   72.22	   67.81	   51.85	   45.42	   39.32	   33.22	   78.40	   72.92	   68.09	   63.08	   52.57	   46.43	   40.03	   33.66	  
MapSplice	   90.53	   92.59	   93.33	   92.47	   84.70	   84.88	   85.59	   85.98	   91.90	   91.77	   91.97	   91.48	   83.57	   83.67	   84.23	   84.73	  
STAR	   79.41	   81.17	   78.07	   60.80	   66.65	   61.01	   55.04	   41.48	   85.05	   80.12	   75.03	   58.85	   66.64	   61.25	   55.01	   41.49	  
Table 2.9 The recall rates of pair and spliced pair alignments for true 
mismatches (SNPs) and sequencing-error mismatches 
M0 is the sensitivity of read alignments with zero mismatches.  M1 is the sensitivity of 
alignments with one mismatch.  M2 and M3 are similarly defined with mismatches of 1, 2, 
and ≥3, respectively.  J0 is the sensitivity of spliced alignments with zero mismatches.  J1, J2, 





Corresponding tables for Figures 2.3-2.7 




realignment	   54,956,129	   77,364,055	   87,355,369	   93,265,424	  
TopHat	   50,422,413	   73,228,140	   84,633,702	   92,396,448	  
GSNAP	   52,255,865	   74,247,781	   84,946,229	   91,598,102	  
MapSplice	   48,896,741	   70,032,327	   81,847,468	   90,360,661	  






realignment	   55,634,580	   77,988,848	   88,370,540	   94,752,200	  
TopHat	   55,225,852	   77,447,497	   87,992,406	   94,596,600	  
GSNAP	   54,666,282	   76,642,607	   86,835,392	   93,005,273	  
RUM	   54,949,609	   76,963,699	   87,157,875	   93,352,293	  
STAR	   54,326,036	   75,730,313	   84,957,399	   89,844,775	  
Table 2.10 Table for Figure 2.3. 





















































































































































































Table 2.11 Table for Figure 2.4. 
 




realignment	   16,696,682	   27,353,265	   33,139,753	   36,839,143	  
TopHat	   14,344,271	   24,456,802	   30,630,922	   35,199,608	  
GSNAP	   15,546,886	   25,853,039	   31,925,593	   36,108,336	  
MapSplice	   13,835,185	   22,781,288	   28,568,799	   32,999,167	  






realignment	   17,091,131	   27,818,953	   33,766,156	   37,699,996	  
TopHat	   16,985,383	   27,661,740	   33,579,775	   37,494,323	  
GSNAP	   16,890,487	   27,569,140	   33,566,349	   37,503,456	  
RUM	   16,923,302	   27,536,281	   33,397,563	   37,208,206	  
STAR	   16,815,984	   27,361,365	   33,191,954	   36,933,241	  
Table 2.12 Table for Figure 2.5. 
 











6,670,997	   10,434,104	   12,349,897	   13,496,341	  
TopHat	   3,816,460	   6,195,116	   7,628,348	   8,708,508	  
GSNAP	   5,507,359	   8,787,161	   10,773,698	   12,226,898	  
MapSplice	   5,438,391	   8,701,358	   10,775,190	   12,389,538	  






7,357,496	   11,476,154	   13,743,868	   15,276,373	  
TopHat	   7,346,821	   11,464,534	   13,733,001	   15,272,369	  
GSNAP	   7,121,858	   11,156,844	   13,436,485	   15,009,697	  
RUM	   7,088,842	   11,048,936	   13,233,486	   14,714,367	  













7,193,604	   11,468,318	   13,694,621	   15,045,756	  
TopHat	   3,988,139	   6,523,309	   8,072,162	   9,282,468	  
GSNAP	   5,630,093	   9,002,188	   11,049,842	   12,550,023	  
MapSplice	   5,710,435	   9,395,612	   11,990,324	   14,137,678	  






7,868,376	   12,481,943	   15,047,081	   16,764,777	  
TopHat	   7,511,707	   11,740,351	   14,073,199	   15,656,508	  
GSNAP	   7,245,286	   11,371,551	   13,710,608	   15,328,468	  
RUM	   7,195,805	   11,231,525	   13,463,953	   14,983,419	  
STAR	   7,169,487	   11,224,944	   13,458,212	   14,917,855	  
Table 2.13 Table for Figure 2.6. 
 




0	   54,956,129	   77,364,055	   87,355,369	   93,265,424	  
Realignment	  
1	  
54,508,641	   77,227,362	   87,334,380	   93,272,963	  
Realignment	  
2	  
53,007,141	   76,631,857	   87,168,673	   93,244,130	  
No	  





0	   17,516,565	   24,088,224	   26,632,215	   27,754,233	  
Realignment	  
1	  
14,179,269	   19,895,371	   22,278,929	   23,389,758	  
Realignment	  
2	  
12,755,976	   17,578,938	   19,577,384	   20,558,593	  
No	  
Realignment	   10,238,968	   14,232,391	   15,847,929	   16,601,804	  
Table 2.14 Table for Figure 2.7. 
 
Alignment rates for reads of different lengths (error-free) 
 
In addition to 100 bp simulated reads in the main text we also generated single 
and paired-end reads of different lengths (50, 150, 200 bp), in order to check how 




fragment lengths 200, 250, 350, 450 bp for read lengths 50, 100, 150, 200 bp, 
respectively.  Figure 2.9 shows TopHat2 performs better than the other programs for 
different read lengths. TopHat2 also outputs much more accurate alignments for 
spliced reads and spliced reads with small anchors.  These results suggest that 
TopHat2 may be the better choice for longer reads (≥150 bp) that will likely become 
prevalent in the near future, as well as for currently available reads (50 ~ 100 bp). 
 
Figure 2.9 Mapping accuracy in different read lengths 
Using simulated reads (20 million reads and 20 million pairs), the figure shows the ratio of 
correctly aligned reads (bottom) or pairs (top) for read alignment (the left column), spliced 
read alignment (the middle column), and spliced read alignment with small anchors (the right 
column). 
Simulation of reads with indels and mismatches 
We used the transcript expression model from the Flux simulator [49] to 
generate RNA-seq reads from the protein coding genes found in the Ensembl human 
gene annotation, release 66.  First, the transcripts from the protein coding genes are 
randomly ranked.  Then, the expression levels of the transcripts are modeled as 
Alignment Spliced alignment Spliced alignment with small anchor
● ● ● ●






































































where ! is the rank number of a transcript, !! = 5  ×  10!, !! = 9500, and ! =   −0.6. 
Reads are simulated for the purpose of testing the alignment programs instead 
of trying to precisely mimic real RNA-seq experiments.  When generating reads with 
true indels, we include at most one indel per exon in a way that if the length of an 
exon L is greater than or equal to 1000 bp, we place either an insertion (50%) or a 
deletion (50%) into the exon at a random location, otherwise an indel is introduced 
into a random location of the transcript with the chance of !
!"""
.  Reads are generated 
from these transcripts so that they share the same changes. For reads with true 
mismatches we change the nucleotides of each transcript in such a way that the 
average distance between two nearby mismatches is 150.5 bp and the distribution of 
the distance is uniform (1 to 300).  Reads are then generated from these modified 
transcripts.  Reads with either indels or mismatches from sequencing errors are 
simulated in the same way except the transcript being used is changed every time a 
read is generated. 
Figure 2.10 shows the proportions of reads spanning multiple exons, which 
increase approximately from 19% to 46% as the length of reads increases from 50 to 
150 bp.  On the other hand, as we may expect, the fragment length does not affect the 






Figure 2.10 Proportions of spliced reads (various read and fragment lengths) 
This figure shows proportions of spliced reads from different read lengths (50 to 150 bp) and 
fragment lengths (200 to 300 bp).  For each fragment length (200, 220, 240, 260, 280, 300 
bp), a whisker box plot shows 100 simulation results (the percentage of spliced reads) for 


















































































































































































Runtime and memory usage 
 
With ~130 million paired-end reads from Chen et al. [44], we ran each 
program using 8 threads on a Linux machine with memory of 256GB and 48 AMD 
processors (2.1GHz).  Runtime (or wall time) and peak memory usage were measured 
using the GNU time program as shown in Table 2.15. 















(Default:	  genome	  and	  spliced	  
mapping)	  
















realignment	  edit	  distance	  of	  0)	  







GSNAP	  2013-­‐01-­‐23	   55h	  26m	   7.6	   -­‐-­‐max-­‐mismatches=3	  	  -­‐N	  1	  
RUM	  1.12_01	   26h	  34m	   *36.4	  	   	  
MapSplice	  1.15.2	   44h	  50m	   3.7	   min_missed_seg	  =	  0	  
STAR	  2.3.0e	   32m	   27.8	  
-­‐-­‐outFilterMatchNmin	  97	  	  





Table 2.15 Runtime and memory usage of RNA-seq alignment software  
Note the last column “Parameters” shows specific parameters for each program to allow a 
read to be aligned with edit distance of 0, 1, 2, and 3.  Parameters for specifying genome, 
gene annotation, RNA-seq read files, and the number of threads are not shown.  The version 
of each program is shown in blue color in the first column.  *Note that RUM uses separate 
processes, each of which consisted of Bowtie (2394MB) and BLAT (4660MB), requiring a 
total of 36.4GB memory when using 8 threads. 
Specific program parameters 























GSNAP -N 1 
RUM Yes  
MapSplice 
No 

































































GSNAP --max-mismatches=3 -N 1 
RUM Yes  
MapSplice 
No 








of a large set 
of real RNA-
seq reads 


























RUM Yes  




--outFilterScoreMin 90  
--outFilterMismatchNmax 3 
Table 2.16 Specific program parameters 
Program parameters to specify genome, gene annotation, and RNA-seq read files are given in 
the table (the number of threads is not shown).  Note that for simulation data set, a TopHat 
option “--read-realign-edit-dist” can be used to realign reads in the spliced alignment phase 














1 553 (1.7%) 4.66 x 2.73 7.33 x 4.30 
2 113 (0.4%) 3.51 x 10.08 3.97 x 11.39 
3 49 (0.2%) 0.62 x 4.13 1.05 x 6.96 
4 27 (0.1%) 1.32 x 15.82 1.52 x 18.30 
≥5 130 (0.4%) 3.61 x 9.01 5.23 x 13.04 
Total (≥1)	 872/32,439 (2.7%) 13.72 x 5.11 19.10 x 7.11 
Table 2.17 The expression levels of genes with pseudogene copies 
















1 267 (1.31%) 6.88 x 5.26 9.55 x 7.30 
2 47 (0.23%) 6.31 x 27.42 6.07 x 26.39 
3 21 (0.10%) 1.27 x 12.38 1.97 x 19.15 
4 16 (0.08%) 0.84 x 10.73 1.02 x 13.02 
≥5 40 (0.20%) 6.73 x 34.33 7.92 x 40.45 
Total (≥1)	 391/20,417 (1.92%) 22.03 x 11.50 26.54 x 13.86 
Table 2.18 The expression levels of protein-coding genes with processed 
pseudogene copies 






Chapter 3: TopHat-Fusion: an algorithm for discovery of novel 
fusion transcripts 
 
I have developed novel algorithms and them into TopHat-Fusion in order to 
discover transcripts representing fusion gene products, which result from the 
breakage and re-joining of two different chromosomes, or from rearrangements 
within a chromosome.  TopHat-Fusion is a part of TopHat2 with the simple command 
line switch, an efficient program that aligns RNA-seq reads without relying on 
existing annotation.  Because it is independent of gene annotation, TopHat-Fusion 
can discover fusion products deriving from known genes, unknown genes and 
unannotated splice variants of known genes.  Using RNA-seq data from breast and 
prostate cancer cell lines, we detected both previously reported and novel fusions 




Direct sequencing of messenger RNA transcripts using the RNA-seq protocol 
[5-7] is rapidly becoming the method of choice for detecting and quantifying all the 
genes being expressed in a cell.  One advantage of RNA-seq is that, unlike microarray 
expression techniques, it does not rely on pre-existing knowledge of gene content, 
and therefore it can detect entirely novel genes and novel splice variants of existing 




seq experiments must be able to align the transcript sequences anywhere on the 
genome, without relying on existing annotation.  TopHat [23] was one of the first 
spliced alignment programs able to perform such ab initio spliced alignment, and in 
combination with the Cufflinks program [20], it is part of a software analysis suite 
that can detect and quantify the complete set of genes captured by an RNA-seq 
experiment. 
In addition to detection of novel genes, RNA-seq has the potential to discover 
genes created by complex chromosomal rearrangements.  ‘Fusion’ genes formed by 
the breakage and re-joining of two different chromosomes have repeatedly been 
implicated in the development of cancer, notably the BCR/ABL1 gene fusion in 
chronic myeloid leukemia [17, 25, 26].  Fusion genes can also be created by the 
breakage and rearrangement of a single chromosome, bringing together transcribed 
sequences that are normally separate.  As of November 2012, the Mitelman database 
[27] documented nearly 62,000 cases of chromosome aberrations and gene fusions in 
cancer.  Discovering these fusions via RNA-seq has a distinct advantage over whole-
genome sequencing, due to the fact that in the highly rearranged genomes of some 
tumor samples, many rearrangements might be present although only a fraction might 
alter transcription.  RNA-seq identifies only those chromosomal fusion events that 
produce transcripts.  It has the further advantage that it allows one to detect multiple 
alternative splice variants that might be produced by a fusion event.  However, if a 
fusion involves only a non-transcribed promoter element, RNA-seq will not detect it. 
In order to detect such fusion events, special purpose software is needed for 




we describe a new method, TopHat-Fusion, designed to capture these events.  We 
demonstrate its effectiveness on six different cancer cell lines, in each of which it 
found multiple gene fusion events, including both known and novel fusions.  
Although other algorithms for detecting gene fusions have been described recently 
[18, 50], these methods use unspliced alignment software (for example, Bowtie [48] 
and ELAND [51]) and rely on finding paired reads that map to either side of a fusion 
boundary.  They also rely on known annotation, searching known exons for possible 
fusion boundaries.  In contrast, TopHat-Fusion directly detects individual reads (as 
well as paired reads) that span a fusion event, and because it does not rely on 
annotation, it finds events involving novel splice variants and entirely novel genes. 
Other recent computational methods that have been developed to find fusion 
genes include SplitSeek [52], a spliced aligner that maps the two non-overlapping 
ends of a read (using 21 to 24 base anchors) independently to locate fusion events.  
This is similar to TopHat-Fusion, which splits each read into several pieces, but 
SplitSeek supports only SOLiD reads.  A different strategy is used by Trans-ABySS 
[53], a de novo transcript assembler, which first uses ABySS [54] to assemble RNA-
seq reads into full-length transcripts.  After the assembly step, it then uses BLAT [55] 
to map the assembled transcripts to detect any that discordantly map across fusion 
points.  This is a very time-consuming process: it took 350 CPU hours to assemble 
147 million reads and >130 hours for the subsequent mapping step. ShortFuse [56] is 
similar to TopHat in that it first uses Bowtie to map the reads, but like other tools it 




different alignment program for its initial alignments, but is similar to TopHat-Fusion 
in employing a series of sophisticated filters to remove false positives. 
TopHat-Fusion is incorporated into TopHat2 with the simple command line 
switch and the filtering step of TopHat-Fusion is also included in TopHat2 package.  




The first step in analysis of an RNA-seq data set is to align (map) the reads to 
the genome, which is complicated by the presence of introns.  Because introns can be 
very long, particularly in mammalian genomes, the alignment program must be 
capable of aligning a read in two or more pieces that can be widely separated on a 
chromosome.  The size of RNA-seq data sets, numbering in the tens of millions or 
even hundreds of millions of reads, demands that spliced alignment programs also be 
very efficient.  The TopHat program achieves efficiency primarily through the use of 
the Bowtie aligner [48], an extremely fast and memory-efficient program for aligning 
unspliced reads to the genome.  TopHat uses Bowtie to find all reads that align 
entirely within exons, and creates a set of partial exons from these alignments.  It then 
creates hypothetical intron boundaries between the partial exons, and uses Bowtie to 
re-align the initially unmapped (IUM) reads and find those that define introns. 
TopHat-Fusion implements several major changes to the original TopHat 
algorithm, all designed to enable discovery of fusion transcripts (Figure 3.1).  After 




the final segment being 25 bp or longer; for example, an 80-bp read will be split into 
three segments of length 25, 25, and 30 (Figure 3.2). 
 
Figure 3.1 TopHat-Fusion pipeline 
TopHat-Fusion consists of two main modules: (1) finding candidate fusions and aligning 
reads across them; and (2) filtering out false fusions using a series of post-processing 
routines. 
 
The algorithm then uses Bowtie to map the 25-bp segments to the genome.  
For normal transcripts, the TopHat algorithm requires that segments must align in a 
pattern consistent with introns; that is, the segments may be separated by a user-
defined maximum intron length, and they must align in the same orientation along the 
TopHat-Fusion
Initial read mapping, where each end of
paired reads is mapped independently
Segment mapping of unmapped reads
Identifying candidate fusions using segment and read mappings
Constructing and indexing spliced fusion con-
tigs, and then remapping segments against them
Stitching segments to produce full read alignments
Selecting the best read and mate pair alignments,
and reporting fusions supported by those alignments
single or paired-end reads
mappings of reads
unmapped reads, which are split into segments
mappings of segments from unmapped reads
intermediate fusions
mappings of segments against fusions
mappings of reads initially unmapped (by stitching)
Post-processing steps
Filtering fusions based on the number of
reads and mate pairs that support fusions
Sorting fusions based on scores of read distributions around them
Read alignments
Fusions with statistics (# of reads and




same chromosome.  For fusion transcripts, TopHat-Fusion relaxes both these 
constraints, allowing it to detect fusions across chromosomes as well as fusions 
caused by inversions. 
 
Figure 3.2 Aligning a read that spans a fusion point 
(a) An initially unmapped read of 75 bp is split into three segments of 25 bp, each of which is 
mapped separately. As shown here, the left (red) and right (blue) segments are mapped to two 
different chromosomes, i and j. (b) The unmapped green segment is used to find the precise 
fusion point between i and j. This is done by aligning the green segment to the sequences just 
to the right of the red segment on chromosome i and just to the left of the blue segment on 
chromosome j. 
 
Following the mapping step, we filter out candidate fusion events involving 
multi-copy genes or other repetitive sequences, on the assumption that these 
sequences cause mapping artifacts.  However, some multi-mapped reads (reads that 
align to multiple locations) might correspond to genuine fusions: for example, in 
Kinsella et al. [56], the known fusion genes HOMEZ-MYH6 and KIAA1267-ARL17A 
IUM read (75bp)
TTAACACTATCTAAAATCAATTTTC TTTTACAGGTACGGTCAACAGTAAC AATGATAGCGACGACTGCGTCATAG
segment 1 (25bp) segment 2 (25bp) segment 3 (25bp)
TTAACACTATCTAAAATCAATTTTC AATGATAGCGACGACTGCGTCATAG
chr i GAATTTCCTG TTAACACTATCTAAAATCAATTTTC TTTTACAGGTACATTGTAGTTTTAT GAATATGGCTCCGGTCAACAGTAAC AATGATAGCGACGACTGCGTCATAG TCAGTGAATC chr j
135223330 135223354 287237735 287237711 (genomic coordinate)
(a) mapping segments on chr i and chr j
TTTTACAGGTAC GGTCAACAGTAAC
TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC GGTCAACAGTAAC AATGATAGCGACGACTGCGTCATAG
chr i GAATTTCCTG TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC ATTGTAGTTTTAT GAATATGGCTCC GGTCAACAGTAAC AATGATAGCGACGACTGCGTCATAG TCAGTGAATC chr j
135223366 287237748
chr i GAATTTCCTG TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC GGTCAACAGTAAC AATGATAGCGACGACTGCGTCATAG TCAGTGAATC chr j
a break point




were supported by 2 and 11 multi-mapped read pairs, respectively. Therefore, instead 
of eliminating all multi-mapped reads, we impose an upper bound M (default M = 2) 
on the number of mappings per read. If a read or a pair of reads has M or fewer multi-
mappings, then all mappings for that read are considered.  Reads with >M mappings 
are discarded. 
To further reduce the likelihood of false positives, we require that each read 
mapping across a fusion point have at least 13 bases matching on both sides of the 
fusion, with no more than two mismatches.  We consider alignments to be fusion 
candidates when the two ‘sides’ of the event either (a) reside on different 
chromosomes or (b) reside on the same chromosome and are separated by at least 
100,000 bp.  The latter are the results of intra-chromosomal rearrangements or 
possibly read-through transcription events.  We chose the 100,000-bp minimum 
distance as a compromise that allows TopHat-Fusion to detect intra-chromosomal 
rearrangements while excluding most but not all read-through transcripts.  Intra-
chromosomal fusions may also include inversions. 
As shown in Figure 3.2a, after splitting an IUM read into three segments, the 
first and last segments might be mapped to two different chromosomes.  Once this 
pattern of alignment is detected, the algorithm uses the three segments from the IUM 
read to find the fusion point.  After finding the precise location, the segments are re-
aligned, moving inward from the left and right boundaries of the original DNA 
fragment.  The resulting mappings are combined together to give full read alignments. 
For this re-mapping step, TopHat-Fusion extracts 22 bp immediately flanking each 




3.3).  It then creates a Bowtie index (using the bowtie-build program [48]) from the 
spliced contigs.  Using this index, it runs Bowtie to align all the segments of all IUM 
reads against the spliced fusion contigs.  For a 25-bp segment to be mapped to a 44-
bp contig, it has to span the fusion point by at least 3 bp.  
 
Figure 3.3 Mapping against fusion points 
Bowtie is used to align all segments from the initially unmapped (IUM) reads against spliced 
fusion contigs, shown in gray on the right. For example, the brown read on the top left aligns 
to the first spliced fusion contig on the top right. 
 
In addition to finding fusion points using three (or more) segments as 
illustrated in Figure 3.2, TopHat-Fusion is able to identify fusions using two segments 
(the minimum number of segments required), and paired-end alignments are used to 
make this searching process more sensitive (Figure 3.4).  By allowing a few 
mismatches when TopHat uses Bowtie to map segments from the initially unmapped 
(IUM) reads, it is possible that a segment will be mapped a few bases past a fusion 
point.  This allows TopHat-Fusion to identify fusions with just two segments by 
realigning them to two chromosomes, or two different parts of a chromosome.  


















(a) mapping segments against spliced fusion contigs
IUM read 1
chr i:3250752 TGTCCTTAGAATAATCAAAGATCTTCCCAGAATCGCCATTTAAGTGGGCGCAACTCGGTCCCCTTCCGGGAAAAG chr i:3250826


















segment approach, which allows middle segments to span a fusion point as well as a 
few boundary base pairs of the first and third segments, it turns out that this approach 
is quite effective considering the very deep coverage often available in RNA-seq data 
sets.  As shown in Figure 3.4b, the alignment of a partner read is also used to identify 
a possible small range in which a fusion point may lie. 
 
Figure 3.4 Finding fusions using two segments and partner reads 
(a) TopHat allows one to three mismatches when mapping segments using Bowtie, which 
enables segments to be mapped even if a few bases cross a fusion point (the last two bases of 
the red segment, GG). These two segments, mapped to two different chromosomes, are used 
to identify a fusion point. (b) For paired-end reads, the mapped position of the partner read is 
used to narrow down the range of a fusion point. The second segment (shown in green) 
cannot be mapped because it spans a fusion point. Here, its partner read is mapped and the 
IUM read (50bp)
AATCAATTTTCTTTTACAGGTACGG TCAACAGTAACAATGATAGCGACGA
segment 1 (25bp) segment 2 (25bp)
AATCAATTTTCTTTTACAGGTACGG TCAACAGTAACAATGATAGCGACGA
chr i CACTATCTAA AATCAATTTTCTTTTACAGGTACAT TGTAGTTTTATTATTTGCCCAATGG GCTGAAATGGAGAATATGGCTCCGG TCAACAGTAACAATGATAGCGACGA CTGCGTCATA chr j
two mismatches
135223344 135223368 287237746 287237722 (genomic coordinate)
chr i CACTATCTAA AATCAATTTTCTTTTACAGGTAC GG TCAACAGTAACAATGATAGCGACGA CTGCGTCATA chr j
a break point
(a) finding a fusion in case of two segments
IUM read (50bp) partner read (50bp)
TTAACACTATCTAAAATCAATTTTC TTTTACAGGTACGGTCAACAGTAAC
segment 1 (25bp) segment 2 (25bp)
CTATGTAA...TTTAACTGA
read
(1) TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC (3) (2) GGTCAACAGTAAC CTATGTAA...TTTAACTGA (1)
chr i GAATTTCCTG TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC ATTGTAGTTTTAT GAATATGGCTCC GGTCAACAGTAAC AATGATAGCG...CTAG CTATGTAA...TTTAACTGA chr j
135223330 135223354 287237748 287237685
chr i GAATTTCCTG TTAACACTATCTAAAATCAATTTTC TTTTACAGGTAC GGTCAACAGTAAC AATGATAGCG...CTAG CTATGTAA...TTTAACTGA chr j
a break point




fusion point is likely to be located within the inner mate distance ± standard deviation of the 
left genomic coordinate of the partner read. TopHat-Fusion is able to use this relatively small 
range to efficiently map the right part of the second segment to the right side of a fusion (case 
2). The left part of the second segment is aligned to the right side of the mapped first segment 
(case 3). 
 
After identifying fusion points in the above step, and mapping segments 
against such fusions, it is necessary to connect the mapped segments to make a full 
read alignment, which is one of the most complicated processes in TopHat-Fusion.  
Given the mappings of the segments comprising a read, TopHat-Fusion stitches them 
together to produce full-length read alignments according to the following rules 
(illustrated in Figure 3.5).  (1) Two consecutive segments of a read are aligned on the 
same chromosome with the same orientation, and the right genomic coordinate of a 
segment corresponds to the left coordinate of its subsequent segment or there is a 
junction or a deletion to fill the gap between two consecutive subsequences.  (2) 
There is a fusion that connects the segments available.  This stitching process is done 
by depth first search; i.e., given a first segment, TopHat-Fusion examines every 
second segment to check if any of them can be glued to the first one, and if there is 
such a second segment, it searches all the third segments.  During the search process, 






Figure 3.5 Stitching segments to produce a full read alignment 
(a) The segment in the third row for segment 1 and the one in the first row for segment 2 are 
connected because they are on the same chromosome (i) in the forward direction and with 
adjacent coordinates. These are then matched to the second row in segment 3 and glued 










chr k:87555622 chr k:87555598 chr i:135223355 chr j:287237736 chr k:87553622 chr k:87553596
chr m:314555662 chr m:314553638 chr k:87555597 chr k:87555573 chr j:287237735 chr j:287237711
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together, producing the full-length read alignment at the bottom. (b) TopHat-Fusion tries to 
connect the segment in the second row for segment 1 with segments in the first and second 
rows for segment 2, but neither succeeds. Case 1 would require two fusion points in the same 
read, and case 2 cannot be fused with consistent coordinates. (c) Attempts to connect the 
segment in the second row for segment 2 with the one in the first row in segment 3: in case 3, 
there is no intron available, there is no fusion in case 4, and case 5 would require more than 
one fusion. 
 
After stitching together the segment mappings to produce full alignments, we 
collect those reads that have at least one alignment spanning the entire read.  We then 
choose the best alignment for each read using a heuristic scoring function, defined 
below.  We assign penalties for alignments that span introns (-2), indels (-4), or 
fusions (-4). For each potential fusion, we require that spanning reads have at least 13 
bp aligned on both sides of the fusion point (this requirement alone eliminates many 
false positives).  After applying the penalties, if a read has more than one alignment 
with the same minimum penalty score, then the read with the fewest mismatches is 
selected.  For example, in Figure 3.6, IUM read 1 (in blue) is aligned to three 
different locations: (1) chromosome i with no gap, (2) chromosome j where it spans 
an intron, and (3) a fusion contig formed between chromosome m and chromosome n.  
Our scoring function prefers (1), followed by (2), and by (3). For IUM read 2 (Figure 
3.6, in green), we have two alignments: (1) a fusion formed between chromosome i 
and chromosome j, and (2) an alignment to chromosome k with a small deletion.  






Figure 3.6 Selecting best read alignments 
IUM reads 1 and 2 each have multiple alignments. Read 1 has a gap-free alignment, shown in 
dark blue, which is preferred over the other two alignments shown in lighter shades of blue. 
The gap-free alignment with three mismatches is preferred over the fusion alignment with 
one mismatch. If all alignments have gaps and mismatches, then the algorithm prefers those 
with fewer mismatches, as shown by the dark green alignment for IUM read 2. Full details of 
the scoring function that determines these preferences are described in the Materials and 
methods. 
 
We imposed further filters for each data set: (1) in the breast cancer cell lines 
(BT474, SKBR3, KPL4, MCF7), we required two supporting pairs and the sum of 
spanning reads and supporting pairs to be at least 5; (2) in the VCaP paired-end reads, 
we required the sum of spanning reads and supporting pairs to be at least 10; (3) in 
the UHR paired-end reads, we required (i) three spanning reads and two supporting 
pairs or (ii) the sum of spanning reads and supporting pairs to be at least 10; and (4) 
in the UHR single-end reads, we required two spanning reads.  These numbers were 
determined empirically using known fusions as a quality control.  All candidates that 


















(a) mapping segments against spliced fusion contigs
IUM read 1
chr i:3250752 TGTCCTTAGAATAATCAAAGATCTTCCCAGAATCGCCATTTAAGTGGGCGCAACTCGGTCCCCTTCCGGGAAAAG chr i:3250826


















In order to remove false positive fusions caused by repeats, we extract the two 
23-base sequences spanning each fusion point and then map them against the entire 
human genome.  We convert the resulting alignments into a list of pairs (chromosome 
name, genomic coordinate - for example, chr14:374384).  For each 23-mer adjacent 
to a fusion point, we test to determine if the other 23-mer occurs within 100,000 bp 
on the same chromosome.  If so, then it is likely a repeat and we eliminate the fusion 
candidate.  We further require that at least one side of a fusion contains an annotated 
gene (based on known genes from RefSeq), otherwise the fusion is filtered out.  
These steps alone reduced the number of fusion candidates in our experiments from 





Figure 3.7 Supporting and contradicting evidence for fusion transcripts 
(a) Given a fusion point and the chromosomes (gray) spanning it, single-end and paired-end 
reads (blue) support the fusion. Other reads (red) contradict the fusion by mapping entirely to 
either of the two chromosomes. (b) TopHat-Fusion prefers reads that uniformly cover a 600-
bp window centered in any fusion point. On the upper left, blue reads cover the entire 
window. On the lower left, red reads cover only a narrow window around the fusion. On the 
lower right, reads do not cover part of the 600-bp window. The cases shown in orange will be 
rejected by TopHat-Fusion. 
 
(a) supporting reads in blue and contradicting reads in red
intron
uncovered




As reported in Edgren et al. [18], true fusion transcripts have reads mapping 
uniformly in a wide window across the fusion point, whereas false positive fusions 
are narrowly covered.  Using this idea, TopHat-Fusion examines a 600-bp window 
around each fusion (300-bp each side), and rejects fusion candidates for which the 
reads fail to cover this window (Figure 3.7b).  The final process is to sort fusions 
based on how well-distributed the reads are (Figure 3.8).  The scoring scheme prefers 
alignments that have no gaps (or small gaps) and uniform depth. 
 
Figure 3.8 TopHat-Fusion’s scoring scheme of read distributions 
A scoring scheme of how well distributed reads are around a fusion point; these result scores 
are used to sort the list of candidate fusions. Variables are defined in the main text. 
 
Even with strict parameters for the initial alignment, many of the segments 
will map to multiple locations, which can make it appear that a read spans two 
chromosomes.  Thus the algorithm may find large numbers of false positives, 
primarily due to the presence of millions of repetitive sequences in the human 
genome.  Even after filtering to choose the best alignment per read, the experiments 
reported here yielded initial sets of about 400,000 and 135,000 fusion gene candidates 
from the breast cancer (BT474, SKBR3, KPL4, MCF7) and prostate cancer (VCaP) 
cell lines, respectively.  The additional filtering steps eliminated the vast majority of 










these false positives, reducing the output to 76 and 19 fusion candidates, respectively, 
all of which have strong supporting evidence (Tables 3.2 and 3.3). 
The scoring function used to rank fusion candidates uses the number of paired 
reads in which the reads map on either side of the fusion point in a consistent 
orientation (Figure 3.7a) as well as the number of reads in conflict with the fusion 
point.  Conflicting reads align entirely to either of the two chromosomes and span the 
point at which the chromosome break should occur (Figure 3.7b). 
The overall fusion score is computed as: 
!"#$% = !"#$%& + !"#$%& +min !"#_!"#, !"#$ +min !"#_!"#, !"#$
− !"#$%& − !"#$%& −min !"#_!"#, !"#$ − !"#$
− !"#$ + !"#$ − !"#$ + !"#! ∗!"# _!"# + !"#$
−min 1000,!"#!    
 
where lcount is the number of bases covered in a 300-bp window on the left 
(Figure 3.8), lavg is the average read coverage on the left, max_avg is 300, lgap is the 
length of any gap on the left, rate is the ratio between the number of supporting mate 
pairs and the number of contradicting reads, |lavg - ravg| is a penalty for expression 
differences on either side of the fusion, and dist is the sum of distances between each 
end of a pair and a fusion.  For single-end reads, the rate uses spanning reads rather 
than mate pairs.  The variance in coverage lder is: 






!!!   ,  where lwindow is the size of the left 
window (300 bp). 
 
TopHat-Fusion outputs alignments of singleton reads and paired-end reads 




analyses [57], such as transcript assembly and differential gene expression.  The 
parameters in the filtering steps can be changed as needed for a particular data set. 
3.3 Results 
We tested TopHat-Fusion on RNA-seq data from two recent studies of fusion 
genes: (1) four breast cancer cell lines (BT474, SKBR3, KPL4, MCF7) described by 
Edgren et al. [18] and available from the NCBI Sequence Read Archive 
[SRA:SRP003186]; and (2) the VCaP prostate cancer cell line and the Universal 
Human Reference (UHR) cell line, both from Maher et al. [50].  The data sets 
contained >240 million reads, including both paired-end and single-end reads (Table 
3.1).  We mapped all reads to the human genome (UCSC hg19) with TopHat-Fusion, 
and we identified the genes involved in each fusion using the RefSeq and Ensembl 
human annotations. 
 











Edgren et al. [18] BT474 Paired 100, 200 50 21,423,697 
Edgren et al. [18] SKBR3 Paired 100, 200 50 18,140,246 
Edgren et al. [18] KPL4 Paired 100 50 6,796,443 
Edgren et al. [18] MCF7 Paired 100 50 8,409,785 
Maher et al. [50] VCaP Paired 300 50 16,894,522 
Maher et al. [50] UHR Paired 300 50 25,294,164 
Maher et al. [50] UHR Single  100 56,129,471 
Table 3.1 RNA-seq data used to test TopHat-Fusion 
The data came from two studies, and included four samples from breast cancer cells (BT474, 
SKBR3, KPL4, MCF7), one prostate cancer cell line (VCaP), and two samples from the 
Universal Human Reference (UHR) cell line.  For paired-end data, two reads were generated 
from each fragment; thus the total number of reads is twice the number of fragments. 
One of the biggest computational challenges in finding fusion gene products is 
the huge number of false positives that result from a straightforward alignment 




which allow many reads to align to multiple locations on the genome.  To address this 
problem, we developed strict filtering routines to eliminate the vast majority of 
spurious alignments (see Materials and methods).  These filters allowed us to reduce 
the number of fusions reported by the algorithm from >100,000 to just a few dozen, 
all of which had strong support from multiple reads. 
Overall, TopHat-Fusion found 76 fusion genes in the four breast cancer cell 
lines (Table 3.2; the TopHat-Fusion paper [19], additional file 1) and 19 in the 
prostate cancer (VCaP) cell line (Table 3.3; the TopHat-Fusion paper [19], additional 
file 2).  In the breast cancer data, TopHat-Fusion found 25 out of the 27 previously 
reported fusions [18].  Of the two fusions TopHat-Fusion missed (DHX35-ITCH, 
NFS1-PREX1), DHX35-ITCH was included in the initial output, but was filtered out 
because it was supported by only one singleton read and one mate pair.  The 
remaining 51 fusion genes were not previously reported. In the VCaP data, TopHat-
Fusion found 9 of the 11 fusions reported previously [50] plus 10 novel fusions.  One 
of the missing fusions involved two overlapping genes, ZNF577 and ZNF649 on 





Fusion	  genes	  (left-­‐right)	   Chromosomes	  
(left-­‐right)	  




BT474	   TRPC4AP-­‐MRPL45	   20-­‐17	   33665850	   36476499	   2	   9	  
BT474	   TOB1-­‐SYNRG	   17-­‐17	   48943418	   35880750	   26	   47	  
SKBR3	   TATDN1-­‐GSDMB	   8-­‐17	   125551264	   38066175	   311	   555	  
BT474	   THRA-­‐SKAP1	   17-­‐17	   38243102	   46384689	   28	   46	  
MCF7	   BCAS4-­‐BCAS3	   20-­‐17	   49411707	   59445685	   105	   284	  
BT474	   ACACA-­‐STAC2	   17-­‐17	   35479452	   37374425	   57	   59	  
BT474	   STX16-­‐RAE1	   20-­‐20	   57227142	   55929087	   6	   24	  
BT474	   MED1-­‐ACSF2	   17-­‐17	   37595419	   48548386	   10	   12	  
MCF7	   ENSG00000254868-­‐FOXA1	   14-­‐14	   38184710	   38061534	   2	   22	  
SKBR3	   ANKHD1-­‐PCDH1	   5-­‐5	   139825557	   141234002	   4	   15	  
BT474	   ZMYND8-­‐CEP250	   20-­‐20	   45852972	   34078459	   10	   53	  




SKBR3	   SUMF1-­‐LRRFIP2	   3-­‐3	   4418012	   37170638	   3	   12	  
KPL4	   BSG-­‐NFIX	   19-­‐19	   580779	   13135832	   12	   27	  
BT474	   VAPB-­‐IKZF3	   20-­‐17	   56964574	   37922743	   4	   14	  
BT474	   DLG2-­‐HFM1	   11-­‐1	   85195025	   91853144	   2	   10	  
SKBR3	   CSE1L-­‐ENSG00000236127	   20-­‐20	   47688988	   47956855	   13	   31	  
MCF7	   RSBN1-­‐AP4B1	   1-­‐1	   114354329	   114442495	   6	   7	  
BT474	   MED13-­‐BCAS3	   17-­‐17	   60129899	   59469335	   3	   14	  
MCF7	   ARFGEF2-­‐SULF2	   20-­‐20	   47538545	   46365686	   17	   20	  
BT474	   HFM1-­‐ENSG00000225630	   1-­‐1	   91853144	   565937	   2	   43	  
KPL4	   MUC20-­‐ENSG00000249796	   3-­‐3	   195456606	   195352198	   13	   46	  
KPL4	   MUC20-­‐ENSG00000236833	   3-­‐3	   195456612	   197391649	   8	   15	  
MCF7	   RPS6KB1-­‐TMEM49	   17-­‐17	   57992061	   57917126	   4	   3	  
SKBR3	   WDR67-­‐ZNF704	   8-­‐8	   124096577	   81733851	   3	   3	  
BT474	   CPNE1-­‐PI3	   20-­‐20	   34243123	   43804501	   2	   6	  
BT474	   ENSG00000229344-­‐RYR2	   1-­‐1	   568361	   237766339	   1	   19	  
BT474	   LAMP1-­‐MCF2L	   13-­‐13	   113951808	   113718616	   2	   6	  
MCF7	   SULF2-­‐ZNF217	   20-­‐20	   46415146	   52210647	   11	   32	  
BT474	   WBSCR17-­‐FBXL20	   7-­‐17	   70958325	   37557612	   2	   8	  
MCF7	   ENSG00000224738-­‐TMEM49	   17-­‐17	   57184949	   57915653	   5	   6	  
MCF7	   ANKRD30BL-­‐RPS23	   2-­‐5	   133012791	   81574161	   2	   6	  
BT474	   ENSG00000251948-­‐SLCO5A1	   19-­‐8	   24184149	   70602608	   2	   6	  
BT474	   GLB1-­‐CMTM7	   3-­‐3	   33055545	   32483333	   2	   6	  
KPL4	   EEF1DP3-­‐FRY	   13-­‐13	   32520314	   32652967	   2	   4	  
MCF7	   PAPOLA-­‐AK7	   14-­‐14	   96968936	   96904171	   3	   3	  
BT474	   ZNF185-­‐GABRA3	   X-­‐X	   152114004	   151468336	   2	   3	  
KPL4	   PPP1R12A-­‐SEPT10	   12-­‐2	   80211173	   110343414	   3	   8	  
BT474	   SKA2-­‐MYO19	   17-­‐17	   57232490	   34863349	   5	   12	  
MCF7	   LRP1B-­‐PLXDC1	   2-­‐17	   142237963	   37265642	   2	   5	  
BT474	   NDUFB8-­‐TUBD1	   10-­‐17	   102289117	   57962592	   1	   49	  
BT474	   ENSG00000225630-­‐
NOTCH2NL	  
1-­‐1	   565870	   145277319	   1	   18	  
SKBR3	   CYTH1-­‐EIF3H	   17-­‐8	   76778283	   117768257	   18	   37	  
BT474	   PSMD3-­‐ENSG00000237973	   17-­‐1	   38151673	   566925	   1	   12	  
BT474	   STARD3-­‐DOK5	   17-­‐20	   37793479	   53259992	   2	   10	  
BT474	   DIDO1-­‐TTI1	   20-­‐20	   61569147	   36634798	   1	   10	  
BT474	   RAB22A-­‐MYO9B	   20-­‐19	   56886176	   17256205	   8	   20	  
KPL4	   PCBD2-­‐ENSG00000240967	   5-­‐5	   134259840	   99382129	   1	   32	  
SKBR3	   RARA-­‐PKIA	   17-­‐8	   38465535	   79510590	   1	   5	  
BT474	   MED1-­‐STXBP4	   17-­‐17	   37607288	   53218672	   13	   11	  
KPL4	   C1orf151-­‐ENSG00000224237	   1-­‐3	   19923605	   27256479	   1	   5	  
SKBR3	   RNF6-­‐FOXO1	   13-­‐13	   26795971	   41192773	   2	   13	  
SKBR3	   BAT1-­‐ENSG00000254406	   6-­‐11	   31499072	   119692419	   2	   30	  
BT474	   KIAA0825-­‐PCBD2	   5-­‐5	   93904985	   134259811	   1	   19	  
SKBR3	   PCBD2-­‐ANKRD30BL	   5-­‐2	   134263179	   133012790	   1	   5	  
BT474	   ENSG00000225630-­‐
MTRNR2L8	  
1-­‐11	   565457	   10530147	   1	   35	  
BT474	   PCBD2-­‐ENSG00000251948	   5-­‐19	   134260431	   24184146	   2	   6	  
BT474	   ANKRD30BL-­‐
ENSG00000237973	  
2-­‐1	   133012085	   567103	   2	   8	  
KPL4	   ENSG00000225972-­‐
HSP90AB1	  
1-­‐6	   564639	   44220780	   1	   7	  
BT474	   MTIF2-­‐ENSG00000228826	   2-­‐1	   55470625	   121244943	   1	   11	  
BT474	   ENSG00000224905-­‐PCBD2	   21-­‐5	   15457432	   134263223	   2	   7	  
BT474	   RPS6KB1-­‐SNF8	   17-­‐17	   57970686	   47021335	   48	   57	  
BT474	   MTRNR2L8-­‐PCBD2	   11-­‐5	   10530146	   134263156	   1	   6	  
BT474	   RPL23-­‐ENSG00000225630	   17-­‐1	   37009355	   565697	   3	   19	  
BT474	   MTRNR2L2-­‐PCBD2	   5-­‐5	   79946288	   134259832	   1	   5	  




SKBR3	   PCBD2-­‐ENSG00000239776	   5-­‐12	   134263289	   127650986	   2	   3	  
BT474	   ENSG00000239776-­‐
MTRNR2L2	  
12-­‐5	   127650981	   79946277	   2	   3	  
BT474	   JAK2-­‐TCF3	   9-­‐19	   5112849	   1610500	   1	   46	  
KPL4	   NOTCH1-­‐NUP214	   9-­‐9	   139438475	   134062675	   3	   5	  
BT474	   MTRNR2L8-­‐TRBV25OR92	   11-­‐9	   10530594	   33657801	   4	   4	  
BT474	   MTRNR2L8-­‐AKAP6	   11-­‐14	   10530179	   32953468	   1	   5	  
BT474	   ENSG00000230916-­‐PCBD2	   X-­‐5	   125606246	   134263219	   1	   5	  
MCF7	   ENSG00000226505-­‐MRPL36	   2-­‐5	   70329650	   1799907	   5	   20	  
SKBR3	   CCDC85C-­‐SETD3	   14-­‐14	   100002351	   99880270	   5	   6	  
BT474	   RPL23-­‐ENSG00000230406	   17-­‐2	   37009955	   222457168	   109	   5	  
Table 3.2 76 candidate fusions in breast cancer samples 
The 76 candidate fusion genes found by TopHat-Fusion in four breast cancer cell lines 
(BT474, SKBR3, KPL4, MCF7), with previously reported fusions [18] shown in boldface.  
The remaining 51 fusion genes are novel. The fusions are sorted by the scoring scheme 
described in Methods. 
 
Fusion	  genes	  (left-­‐right)	   Chromosomes	  
(left-­‐right)	  




ZDHHC7-­‐ABCB9	   16-­‐12	   85023908	   123444867	   13	   69	  
TMPRSS2-­‐ERG	   21-­‐21	   42879875	   39817542	   7	   285	  
HJURP-­‐EIF4E2	   2-­‐2	   234749254	   233421125	   3	   9	  
VWA2-­‐PRKCH	   10-­‐14	   116008521	   61909826	   1	   10	  
RGS3-­‐PRKAR1B	   9-­‐7	   116299195	   699055	   3	   11	  
SPOCK1-­‐TBC1D9B	   5-­‐5	   136397966	   179305324	   9	   31	  
LRP4-­‐FBXL20	   11-­‐17	   46911864	   37557613	   5	   9	  
INPP4A-­‐HJURP	   2-­‐2	   99193605	   234746297	   6	   12	  
C16orf70-­‐C16orf48	   16-­‐16	   67144140	   67700168	   2	   19	  
NDUFV2-­‐ENSG00000188699	   18-­‐19	   9102729	   53727808	   1	   35	  
NEAT1-­‐ENSG00000229344	   11-­‐1	   65190281	   568419	   1	   17	  
ENSG00000011405-­‐TEAD1	   11-­‐11	   17229396	   12883794	   7	   9	  
USP10-­‐ZDHHC7	   16-­‐16	   84733713	   85024243	   1	   22	  
LMAN2-­‐AP3S1	   5-­‐5	   176778452	   115202366	   15	   2	  
WDR45L-­‐ENSG00000224737	   17-­‐17	   80579516	   30439195	   1	   33	  
RC3H2-­‐RGS3	   9-­‐9	   125622198	   116299072	   3	   11	  
CTNNA1-­‐ENSG00000249026	   5-­‐5	   138145895	   114727795	   1	   12	  
IMMTP1-­‐IMMT	   21-­‐2	   46097128	   86389185	   1	   50	  
ENSG00000214009-­‐PCNA	   X-­‐20	   45918367	   5098168	   1	   24	  
Table 3.3 19 candidate fusions in prostate cancer samples 
19 candidate fusions found by TopHat-Fusion in the VCaP prostate cell line, with previously 
reported fusions [50] indicated in boldface.  Fusion genes are sorted according to the scoring 
scheme described in Methods. 
Figure 3.9 illustrates two of the fusion genes identified by TopHat-Fusion. 
Figure 3.9a shows the reads spanning a fusion between the BCAS3 (breast carcinoma 
amplified sequence 3) gene on chromosome 17 (17q23) and the BCAS4 gene on 
chromosome 20 (20q13), originally found in the MCF7 cell line in 2002 [58]. As 




chromosomes 20 and 17, illustrating the single-base precision enabled by TopHat-
Fusion.  Figure 3.9b shows a novel intra-chromosomal fusion product with similarly 
strong alignment evidence that TopHat-Fusion found in BT474 cells.  This fusion 
merges two genes that are 13 megabases apart on chromosome 17: TOB1 (transducer 
of ERBB2, ENSG00000141232) at approximately 48.9 Mb; and SYNRG (synergin 















































































































































(a) 60 reads aligned by TopHat-Fusion that identify a fusion product formed by the BCAS4 
gene on chromosome 20 and the BCAS3 gene on chromosome 17.  The data contained more 
reads than shown; they are collapsed to illustrate how well they are distributed.  The inset 
figures show the coverage depth in 600-bp windows around each fusion.  (b) 
TOB1(ENSG00000141232)-SYNRG is a novel fusion gene found by TopHat-Fusion, shown 
here with 70 reads mapping across the fusion point.  Note that some of the reads in green 
span an intron (indicated by thin horizontal lines extending to the right), a feature that can be 
detected by TopHat’s spliced alignment procedure. 
 
Single versus paired-end reads  
Using four known fusion genes (GAS6-RASA3, BCR-ABL1, ARFGEF2-
SULF2, and BCAS4-BCAS3), we compared TopHat-Fusion's results using single and 
paired-end reads from the UHR data set (Table 3.4).  All four fusions were detected 
using either type of input data.  Although Maher et al. [50] reported much greater 
sensitivity using paired reads, we found that the ability to detect fusions using single-
end reads, when used with TopHat-Fusion, was sometimes nearly as good as with 
paired reads.  For example, the reads aligning to the BCR-ABL1 fusion provided 
similar support using either single or paired-end data (the TopHat-Fusion paper [19], 
additional file 3).  Among the top 20 fusion genes in the UHR data, 3 had more 
support from single-end reads and 9 had better support from paired-end reads (the 
TopHat-Fusion paper [19], additional file 4).  Note that longer reads might be more 
effective for detecting gene fusions from unpaired reads: Zhao et al. [59] found 4 
inter-chromosomal and 3 intra-chromosomal fusions in a breast cancer cell line 
(HCC1954), using 510,703 relatively long reads (average 254 bp) sequenced using 
454 pyrosequencing technology.  Very recently, the FusionMap system [60] was 
reported to achieve better results, using simulated 75-bp reads, on single-end versus 
















Single	   GAS6-­‐RASA3	   13-­‐13	   114529968	   114751268	   15	  (0.267)	   	  
Paired	   GAS6-­‐RASA3	   13-­‐13	   114529968	   114751268	   10	  (0.198)	   43	  
Single	   BCR-­‐ABL1	   22-­‐9	   23632599	   133655755	   6	  (0.107)	   	  
Single	   BCR-­‐ABL1	   22-­‐9	   23632599	   133729450	   3	  (0.053)	   	  
Paired	   BCR-­‐ABL1	   22-­‐9	   23632599	   133655755	   2	  (0.040)	   7	  
Paired	   BCR-­‐ABL1	   22-­‐9	   23632599	   133729450	   3	  (0.059)	   10	  
Single	   ARFGEF2-­‐SULF2	   20-­‐20	   47538548	   46365683	   17	  (0.302)	   	  
Paired	   ARFGEF2-­‐SULF2	   20-­‐20	   47538545	   46365686	   10	  (0.198)	   30	  
Single	   BCAS4-­‐BCAS3	   20-­‐17	   49411707	   59445685	   25	  (0.445)	   	  
Paired	   BCAS4-­‐BCAS3	   20-­‐17	   49411707	   59445685	   13	  (0.257)	   145	  
Table 3.4 Comparisons: single-end and paired-end reads for finding fusions. 
Comparisons of single-end and paired-end reads as evidence for gene fusions in the Universal 
Human Reference (UHR) cell line (a mixture of multiple cancer cell lines), using the known 
fusions GAS6-RASA3, BCR-ABL1, ARFGEF2-SULF2, and BCAS4-BCAS3.  With 
TopHat-Fusion’s ability to align a read across a fusion, the single-end approach is 
competitive with the paired-end based approach.  RPM is the number of reads that span a 
fusion per millon reads sequenced.  For instance, the RPM of single-end reads in GAS6-
RASA3 is 0.267, which is slightly better than the RPM for paired-end reads.  Single-end 
reads may show higher RPM values than paired-ends in part because single-end reads are 
longer (100 bp) than paired-end reads (50 bp) in these data, and therefore they are more likely 
to span fusions. 
Estimate of the false positive rate 
In order to estimate the false positive rate of TopHat-Fusion, we ran it on 
RNA-seq data from normal human tissue, in which fusion transcripts should be 
absent.  Using paired-end RNA-seq reads from two tissue samples (testes and 
thyroid) from the Illumina Body Map 2.0 data [ENA: ERP000546] (see [45] for the 
download web page), the system reported just one and nine fusion transcripts in the 
two samples, respectively.  Considering that each sample comprised approximately 
163 million reads, and assuming that all reported fusions are false positives, the false 
positive rate would be approximately 1 per 32 million reads.  Some of the reported 
fusions may in fact be chimeric sequences due to ligation of cDNA fragments [61], 
which would make the false positive rate even lower.  For this experiment, we 
required five spanning reads and five supporting mate pairs because the number of 




parameters are changed to one read and two mate pairs, TopHat-Fusion predicts 4 and 
43 fusion transcripts in the two samples, respectively (the TopHat-Fusion paper [19], 
additional file 5). 
Because it is also a standalone fusion detection system, we ran FusionSeq 
(0.7.0) [33] on one of our data sets to compare its performance to TopHat-Fusion. 
FusionSeq consists of two main steps: (1) identifying potential fusions based on 
paired-end mappings; and (2) filtering out fusions with a sophisticated filtration 
cascade containing more than ten filters.  Using the breast cancer cell line MCF7, in 
which three true fusions (BCAS4-BCAS3, ARFGEF2-SULF2, RPS6KB1-TMEM49) 
were previously reported, we ran FusionSeq with mappings from Bowtie that 
included discordantly mapped mate pairs.  Note that FusionSeq was designed to use 
the commercial ELAND aligner, but we used the open-source Bowtie instead.  To do 
this, we aligned each end of every mate pair separately, allowing them to be aligned 
to at most two places, and then combined and converted them to the input format 
required by FusionSeq. 
When we required at least two supporting mate pairs for a fusion (the same 
requirement as for our TopHat-Fusion analysis), FusionSeq missed one true fusion 
(RPS6KB1-TMEM49) because it was supported by only one mate pair.  In contrast, 
TopHat-Fusion found this fusion because it was supported by three mate pairs from 
TopHat-Fusion's alignment algorithm: one mate pair contains a read that spans a 
splice junction, and the other contains a read that spans a fusion point.  These spliced 
alignments are not found by Bowtie or ELAND.  With this spliced mapping 




based on non-gapped aligners.  When the minimum number of mate pairs is reduced 
to 1, FusionSeq found all three known fusions at the expense of increased running 
time (9 hours versus just over 2 hours) and a large increase in the number of 
candidate fusions reported (32,646 versus 5,649). 
Next, we ran all of FusionSeq's filters except two (PCR filter and annotation 
consistency filter) that would otherwise eliminate two of the true fusions. FusionSeq 
reported 14,510 gene fusions (the TopHat-Fusion paper [19], additional file 6), 
compared to just 14 fusions reported by TopHat-Fusion (the TopHat-Fusion paper 
[19], additional file 7), where both found the three known fusions. 
Among those fusions reported by FusionSeq, 13,631 and 276 were classified 
as inter-chromosomal and intra-chromosomal, respectively.  When we used all of 
FusionSeq's filters, it reported 763 candidate fusions that include only one of the three 
known fusions. 
FusionSeq reports three scores for each transcript: SPER (normalized number 
of inter-transcript paired-end reads), DASPER (difference between observed and 
expected SPER), and RESPER (ratio of observed SPER to the average of all SPERs). 
Because RESPER is proportional to SPER in the same data, we used SPER and 
DASPER to control the number of fusion candidates: ARFGEF2-SULF2 (SPER, 
1.289452; DASPER, 1.279144), BCAS4-BCAS3 (0.483544, 0.482379), and 
RPS6KB1-TMEM49 (0.161181, 0.133692).  First, we used SPER of 0.161181 and 
DASPER of 0.133692 to find the minimum set of fusion candidates that include the 




11,774.  Second, we used the SPER and DASPER values from ARFGEF2-SULF2 
and BCAS4-BCAS3, which resulted in 1,269 and 512 predicted fusions, respectively. 
We next compared TopHat-Fusion with deFuse (0.4.2) [34]. deFuse maps 
read pairs against the genome and against cDNA sequences using Bo wtie, and then 
uses discordantly mapped mate pairs to find candidate regions where fusion break 
points may lie.  This allows detection of break points at base-pair resolution, similar 
to TopHat-Fusion.  After collecting sequences around fusion points, it maps them 
against the genome, cDNAs, and expressed sequence tags using BLAT; this step 
dominates the run time. 
Using two data sets - MCF7 and SKBR3 - we ran both TopHat-Fusion and 
deFuse using the following matched parameters: one minimum spanning read, two 
supporting mate pairs, and 13 bp as the anchor length.  For the MCF7 cell line, both 
programs found the three known fusion transcripts.  For the SKBR3 cell line, both 
programs found the same seven fusions out of nine previously reported fusion 
transcripts (one known fusion, CSE1L-ENSG00000236127, was not considered 
because ENSG00000236127 has been removed from the recent Ensembl database).  
Both programs missed two fusion transcripts: DHX35-ITCH and NFS1-PREX1.  
However, TopHat-Fusion had far fewer false positives: it predicted 42 fusions in 
total, while deFuse predicted 1,670 (the TopHat-Fusion paper [19], additional files 7, 
8 and 9). 
Table 3.5 shows the number of spanning reads and supporting pairs detected 
by TopHat-Fusion and deFuse, respectively, for ten known fusions in SKBR3 and 




Considering the fact TopHat-Fusion's mapping step does not use annotations while 
deFuse does, this result illustrates that TopHat-Fusion can be highly sensitive without 
relying on annotations.  Finally, we noted that TopHat-Fusion was approximately 
three times faster: for the SKBR3 cell line, it took 7 hours, while deFuse took 22 

















SKBR3	   TATDN1-­‐GSDMB	   8-­‐17	   311	   555	   322	   95	  
SKBR3	   RARA-­‐PKIA	   17-­‐8	   1	   5	   1	   4	  
SKBR3	   ANKHD1-­‐PCDH1	   5-­‐5	   4	   15	   5	   11	  
SKBR3	   CCDC85C-­‐SETD3	   14-­‐14	   5	   6	   6	   3	  
SKBR3	   SUMF1-­‐LRRFIP2	   3-­‐3	   3	   12	   5	   12	  
SKBR3	   WDR67-­‐ZNF704	   8-­‐8	   3	   3	   3	   2	  
SKBR3	   CYTH1-­‐EIF3H	   17-­‐8	   18	   37	   16	   27	  
MCF7	   BCAS4-­‐BCAS3	   20-­‐17	   105	   284	   106	   105	  
MCF7	   ARFGEF2-­‐SULF2	   20-­‐20	   17	   20	   17	   12	  
MCF7	   RPS6KB1-­‐TMEM49	   17-­‐17	   4	   3	   6	   2	  
Table 3.5 Comparisons of TopHat-Fusion and deFuse 
Comparisons of the number of spanning reads and mate pairs reported by TopHat-Fusion and 
deFuse for 10 previously reported fusion transcripts in the SKBR3 and MCF7 sample data. 
 
Unlike FusionSeq and deFuse (as well as other fusion-finding programs), one 
of the most powerful features in TopHat-Fusion is its ability to map reads across 
introns, indels, and fusion points in an efficient way and report the alignments in a 




Unlike previous approaches based on discordantly mapping paired reads and 
known gene annotations, TopHat-Fusion can find either individual or paired reads 




increase its sensitivity and allow it to find fusions that include novel genes and novel 
splice variants of known genes.  In experiments using multiple cell lines from 
previous studies, TopHat-Fusion identified 34 of 38 previously known fusions. It also 
found 61 fusion genes not previously reported in those data, each of which had solid 







Chapter 4: Reconstruction and Estimation of Fusion Transcripts 
from RNA-Sequencing reads 
 
Fusion transcripts, in which two distinct genes are fused into a single 
messenger RNA, can be created by several mechanisms: (1) chromosomal 
translocations followed by transcription; (2) read-through transcription of two 
adjacent genes; and (3) trans-splicing of two pre-messenger RNA molecules.  One 
very effective way to detect these fusion events is through the use of RNA sequencing 
reads, in which fusion breakpoints can be detected by aligning them back to a normal 
genome.  Reads surrounding and spanning the breakpoints can be assembled into 
fusion transcripts, and the number of reads can be used to estimate expression 
levels.  Two major factors contrive to make this problem more difficult: first, 
eukaryotic genomes are highly repetitive, meaning the reads can align to many 
places; and second, sequencing errors (e.g., random ligation of two cDNAs) can give 
rise to chimeric transcripts.  The problem of separating genuine fusion transcripts 
from these spurious fusion-like transcripts, which are much more numerous than true 
fusions, is a major algorithmic challenge.  The problem is made harder by the fact 
that reads are non-uniformly distributed across transcripts, making low expression 
level transcripts difficult to detect.  A sensitive and accurate method for identifying 
authentic fusions should be able to utilize as much evidence as possible that serves as 
either positive or negative indicators when filtering out potential fusion 




first software systems that can successfully reconstruct and quantify full-length fusion 
gene transcripts.  The newly developed algorithm, which is built on the TopHat2 and 
Cufflinks systems, can be run with or without known gene annotations, and it can 
discover novel fusion isoforms that are transcribed from known or unknown genes. 
 
4.1 Background 
RNA-sequencing technologies [5, 6, 14, 24] enable us to accurately and 
precisely assemble and quantify isoforms of genes being expressed in cells.  In 
addition to addressing this fundamental question, RNA-seq data is used to detect 
fusion genes [17-19].  Fusion genes can be formed at the genomic level when two 
different chromosomes break and rejoin as illustrated in the first example of Figure 
1.3.  Fusion genes may also emerge as a result of the breakage and rearrangement of a 
single chromosome, in which two originally separate sequences are brought together.  
Most fusion genes have a strong association with distinct types of cancerous tumors, 
although a few others have been reported in normal cells [25, 26].  As of November 
2012, the Mitelman database [27] documented about 62,000 cases of chromosome 
aberrations and gene fusions in cancer.  1,078 gene fusions have been reported with 
1309 participating genes.  In addition to these genomic aberrations, fusion events can 
occur during the transcription process known as read-through transcription, when two 
adjacent genes are transcribed into a single pre-RNA molecule, which is then spliced 
into a fusion mRNA.  This is illustrated in the second example of Figure 1.3.  Akiva 
et al. [29] applied a bioinformatics approach using expressed sequence tags (ESTs) 




human genes are associated with such read-through transcription.  Fusion transcripts 
may be formed post-transcriptionally when two different pre-RNA transcripts from 
two genes are spliced together, forming one single mRNA transcript [31].  This 
process, called trans-splicing, is shown in the third example of Figure 1.3. 
Discovering these fusions via RNA-seq has a distinct advantage over whole-
genome sequencing.  This is due to the fact that in the highly rearranged genomes of 
some tumor samples, many rearrangements might be present, although only a fraction 
might alter transcription.  RNA-seq identifies only those chromosomal fusion events 
that produce transcripts.  It has the further advantage that it allows one to detect 
multiple alternative splice variants that might be produced by a fusion event. 
Because it does not rely on annotation, it can find events involving novel splice 
variants and entirely novel genes. 
Previously we developed a fusion-finding program, TopHat-Fusion, which is 
now a part of TopHat2 with a simple command line switch.  It discovers fusion break 
points and it can also align reads across them.  After its filtration step, TopHat-Fusion 
generates highly sensitive and accurate results.  Using RNA-seq reads from four 
breast cancer cell lines (BT474, SKBR3, KPL4, MCF7).  Edgren et al. [18] initially 
reported 24 novel and 3 known fusion genes in this data sample.  When we applied 
TopHat-Fusion to the same data set, 25 of the 27 fusion genes were retrieved, in 
addition to 51 strong candidates for novel fusion genes.  Approximately one year later, 
Kangaspeska et al. [32] (including Edgren as a coauthor) experimentally verified 13 





In addition to detection of fusion break points by TopHat-Fusion, we have 
developed Cufflinks-Fusion, a special purpose program of Cufflinks in order to 
reconstruct and quantify isoforms of a fusion gene.  In diploid cells, we have two 
copies of each gene.  For instance, genes a and b have their homologous copies a’ and 
b’, respectively.  A fusion gene may be formed combining genes a and b, while genes 
a’ and b’ remain intact (not involved).  As a result, several transcripts may be 
comprised of fusion transcripts from the fusion gene as well as normal transcripts 
from the intact genes.  The splicing patterns of fusion genes and their relative 
expression levels may be important to understanding underlying causes of some 
diseases.  Expression levels of fusion genes may also be compared with those of 
normal transcripts from intact genes to provide additional insight.  As described 
previously, TopHat-Fusion provides a list of fusion candidates with high sensitivity 
and low false positive rates.  With more evidence available from Cufflinks-Fusion, 
including multiple isoforms of fusion genes and their abundance levels, we can put 
fusion candidates in order, those with more evidence first and those with less 
evidence after.  This will help biologists quickly interpret the data and decide which 
fusions to address first. 
4.2 Methods 
We have developed TransFUSE, a new pipeline, in order to discover fusion 
transcripts using RNA-seq reads.  TransFUSE was built based on TopHat2 and 
Cufflinks-Fusion and consists of three core steps: (1) fusion alignment of reads 
against the reference genome; (2) assembly and quantification of fusion transcript 




using the evidence collected from the previous steps.  Figure 4.1 illustrates these main 
steps. 
Fusion alignment step 
As illustrated in part 1 of Figure 2, RNA-seq reads are aligned against the 
reference genome, where most of the reads fall into two categories.  The reads either 
lie entirely within an exon or span two or more exons of normal transcripts.  TopHat2 
effectively handles these cases as follows.  Those reads from one exon are aligned by 
TopHat2’s underlying alignment engine Bowtie.  However, multi-exon spanning 
reads need to be aligned across huge gaps due to introns whose length ranges from 50 
to 100,000 base pairs in mammalian cells.  TopHat2 employs a two-step approach to 
align these types of reads.  First, it identifies splice sites of introns.  Second, it stitches 
together the flanking sequences of introns and then maps reads against the spliced 
sequences using Bowtie.  In contrast to this normal alignment, in RNA-seq samples 
from abnormal cells, we need to align reads that originate from “fusion” transcripts 
because fusion transcripts may comprise sequences from two chromosomes, inverted 
sequences from the same chromosome, or two adjacent sequences that were originally 
far from each other on the same chromosome.  TopHat-Fusion algorithm allows reads 
to map across fusion break points, which is now incorporated into TopHat2 with a 
simple command line switch.  TopHat2 reports these normal and fusion alignments in 
Sequence Alignment/Map (SAM) format [35].  SAM is the most popular format that 
many analysis pipelines use as input.  The following steps of TransFUSE also use the 





Assembly and quantification of fusion transcripts 
Fusion transcripts can be reconstructed and quantified, using these fusion 
alignments as input.  We have modified Cufflinks [20] to assemble and quantify 
fusion transcripts based on such mapping information.  We will briefly describe the 
following three steps and then elaborate on the assembly and the quantification steps 
(see the Cufflinks paper for more details).  (i) It goes through the SAM file produced 
from TopHat2 and identifies groups of overlapping alignments into bundles, where 
each bundle is likely to represent reads from a normal gene or a fusion gene (see the 
first part of Figure 4.1).  Once it encounters fusion alignments, it stores the fusion 
break points along with the file offset of the bundle to which the break points belong.  
(ii) It assembles fusion transcripts using a set of bundles of overlapping reads and 
fusion break points collected from the above.  Because fusions usually involve two 
distant genomic locations, it is necessary to examine several bundles at the same time 
and combine them into a fusion bundle group.  There may be several conflicting 
fusion points in the same bundle group.  For instance, one fusion break point may 
involve chromosomes 1 and 7 and another chromosomes 1 and 8.  In this case, the 
fusion point supported by most evidence (e.g. # of fusion reads and # of supporting 
pairs) is chosen while the others being discarded.  This strategy can be used as a 
filtering step for false positive fusions.  (iii) It assesses the abundance level of fusion 
transcripts based on the number of reads and pairs belonging to them.   
 
(ii) Assembly algorithm: for each bundle, single or paired alignments are sorted based 




graph.  If two alignments overlap with each other and they are “compatible” (e.g., 
sharing the same intron or the same break fusion point), then an edge is defined 
between those two vertices.  Based on the graph, Cufflinks finds the minimum 
number of paths covering the graph.  We have extended Cufflinks to handle fusion 
alignments and define new compatibility relationships between several alignment 
types such as non-gapped alignment, spliced alignment, and fusion alignment as 
illustrated in the second part of Figure 4.1. 
 
(iii) Quantification algorithm: Cufflinks-Fusion counts the number of reads or pairs 
by remapping them against each assembled transcript from the above step.  Since 
some transcripts often share some exons of a gene, it is likely that some reads or pairs 
are aligned onto several transcripts.  In order to disambiguate these conflicting cases, 
Cufflinks defines the likelihood of observed data (alignments) given abundance of 
each transcript as parameters.  Cufflinks finds the abundance values that maximize 
the likelihood using EM method.  Cufflinks-Fusion (and therefore TransFUSE) 
reports the expression levels of transcripts using FPKM values.  It also provides row 







Figure 4.1 TransFUSE pipeline 
This pipeline comprises of two underlying software: (1) TopHat2 (with fusion alignment 
option) allows reads to be aligned across fusion break points; (2) Cufflinks-Fusion (an 
enhanced version based of Cufflinks v1.3.1) allows assembly and quantification of isoforms 
of a fusion gene and its wild type genes.  
 
Identification of potential fusion transcripts 
At the fusion alignment step, we usually observe hundreds of thousands fusion 
break points for each sample.  Almost all of these fusion break points are false 
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highly repetitive, with many sequences that are nearly identical to the combined 
sequences of two distant sequences.  This can be problematic because we usually 
allow a few mismatches in the alignment step to compensate for genomic differences 
between the reference and the sequenced genomes.  This problem can be further 
complicated when we use short reads, which are likely to be aligned to more locations 
of the genome.  False fusion discovery may also arise due to artifacts in sequencing 
steps.  For instance, accidental ligation of two cDNAs results in chimeric sequences 
[62]. 
In order to sort though such an enormous number of fusions, we have defined 
some positive and negative evidence that can be used to identify fusions.  Using the 
evidence, TransFUSE eliminates most of the false positive fusions and orders the 
remaining fusions according to the strength of the evidence.  Such evidence includes: 
(1) the number of reads and pairs that support fusion points; (2) sequence similarity; 
(3) longer transcripts with high and uniform coverage by reads; and (4) alternative 
splicing around a fusion break point (involving different flanking exons) and different 
transcript structures on either side or both sides of a fusion gene, which seems to 
happen even when they share the same flanking exons. 
First, our program requires a certain number of reads and pairs that directly 
support a given fusion break point (e.g., 2 reads and 3 pairs).  The more sequenced 
reads we use, the higher number of reads and pairs can be used to filter out fusions.  
Second, the flanking sequences around fusion break points are combined, and they 
are searched against known gene sequences.  If matching with high similarity (e.g. 




As reported in Edgren et al. [18], true fusion transcripts have reads mapping 
uniformly in a wide window across the fusion point, whereas false positive fusions 
are narrowly covered.  Our scoring scheme prefers fusions whose window has no 
gaps (or small gaps), has uniform depth, and is highly covered by reads.  These 
filtration steps usually reduce the number to tens of fusions for a single sample. 
During the assembly step of Cufflinks-Fusion, there may be many fusions in 
the same bundle and conflicting with one another.  Instead of trying to assemble 
every possible fusion, Cufflinks-Fusion chooses just a few of them with the most 
evidence such as the number of supporting reads and pairs, and assembles the 
selected fusions.  Thus, if there are no assembly results for some fusions, it is mostly 
the case that there are some other fusions with better supports.  Put another way, the 
very existence of assemblies can be used as positive evidence: therefore we add some 
positive scores to fusions with assembled transcripts.  In addition, some of real 
fusions may have alternatively spliced transcripts around fusion break points, that is, 
having different exons flanking the break points.  We prefer fusions with such 
evidence by adding some positive scores.  Similarly, if a fusion gene has several 
transcripts with the same exons flanking the same fusion break point, but different 
sets of exons on either side or both sides of the break point, we also add some positive 
scores to those cases.  The structural difference among the transcripts may not be 
direct evidence for true fusions, but it may be worth paying more attention than those 






In order to evaluate the performance of TransFUSE system, we used two data 
sets: 
(1) Edgren et al. [18] and (2) Seo, Ju, Lee et al. [63] as shown in Table 4.1. 
 
 










Edgren et al.  BT474 Paired 100, 200 50 21,423,697 
Edgren et al.  SKBR3 Paired 100, 200 50 18,140,246 
Edgren et al.  KPL4 Paired 100 50 6,796,443 
Edgren et al.  MCF7 Paired 100 50 8,409,785 
Seo, Ju, Lee et al.  LC_S42 Paired 250 101 41045273 
Table 4.1 RNA-seq data used to evaluate TransFUSE. 
The data came from two studies, and included four samples from breast cancer cells (BT474, 
SKBR3, KPL4, MCF7) and one sample (LC_S42) from lung cancer cells.  For paired-end 
data, two reads were generated from each fragment; thus the total number of reads is twice 
the number of fragments. 
We mapped all reads to the human genome (UCSC hg19) with TopHat2 
(v2.0.7) with fusion alignment enabled.  Based on the alignments, we assembled and 
quantified fusion transcripts using Cuffliks-Fusion.  We subsequently applied 
TopHat-Fusion’s filtering algorithm (implemented in “tophat-fusion-post,” which is a 
part of TopHat2) to identify the genes involved in each fusion using the RefSeq and 
Ensembl human annotations (see Methods for detailed description).  63 fusions from 





Fusion	  genes	  (left-­‐right)	   Chromosomes	  
(left-­‐right)	  






SKBR3	   TATDN1-­‐GSDMB	   8-­‐17	   125551265	   38066176	   324	   485	   Yes	  
BT474	   THRA-­‐SKAP1	   17-­‐17	   38243105	   46384692	   25	   53	   Yes	  
BT474	   SNF8-­‐RPS6KB1	   17-­‐17	   47021336	   57970685	   57	   81	   Yes	  
BT474	   MRPL45-­‐TRPC4AP	   17-­‐20	   36476501	   33665848	   3	   11	   Yes	  
MCF7	   USP32-­‐PPM1D	   17-­‐17	   58342772	   58679978	   2	   5	   Yes	  
BT474	   MYO19-­‐SKA2	   17-­‐17	   34863350	   57232491	   5	   14	   Yes	  
MCF7	   BCAS3-­‐BCAS4	   17-­‐20	   59445687	   49411709	   103	   286	   Yes	  
BT474	   SYNRG-­‐TOB1	   17-­‐17	   35880750	   48943418	   28	   87	   Yes	  
BT474	   IKZF3-­‐VAPB	   17-­‐20	   37934019	   56964572	   19	   51	   Yes	  
BT474	   ENSG00000248527-­‐GNAS	   1-­‐20	   569609	   57484588	   1	   6	   No	  




BT474	   MED1-­‐ACSF2	   17-­‐17	   37595417	   48548388	   10	   20	   Yes	  
SKBR3	   SUMF1-­‐LRRFIP2	   3-­‐3	   4418013	   37170639	   5	   7	   Yes	  
SKBR3	   SSH2-­‐EFCAB5	   17-­‐17	   28030079	   28256955	   1	   6	   Yes	  
BT474	   ENSG00000248527-­‐PCBD2	   1-­‐5	   569609	   134263267	   3	   5	   No	  
BT474	   BCAS3-­‐MED13	   17-­‐17	   59469337	   60129897	   3	   14	   Yes	  
BT474	   RAE1-­‐STX16	   20-­‐20	   55929087	   57227142	   6	   35	   Yes	  
BT474	   ACACA-­‐STAC2	   17-­‐17	   35479452	   37374425	   66	   100	   Yes	  
SKBR3	   ZNF704-­‐WDR67	   8-­‐8	   81733849	   124096579	   3	   6	   Yes	  
BT474	   CPNE1-­‐PI3	   20-­‐20	   34243123	   43804501	   2	   6	   Yes	  
KPL4	   BSG-­‐NFIX	   19-­‐19	   580781	   13135834	   12	   39	   Yes	  
BT474	   AHCTF1-­‐NAAA	   1-­‐4	   247094879	   76846963	   12	   41	   Yes	  
MCF7	   TMEM49-­‐RPS6KB1	   17-­‐17	   57917128	   57992063	   6	   8	   Yes	  
SKBR3	   CSE1L-­‐ENSG00000236127	   20-­‐20	   47688989	   47956856	   12	   38	   Yes	  
MCF7	   SULF2-­‐ZNF217	   20-­‐20	   46415148	   52210645	   12	   33	   Yes	  
SKBR3	   MRPS28-­‐TPD52	   8-­‐8	   80831382	   80954854	   3	   4	   Yes	  
SKBR3	   ANKHD1-­‐PCDH1	   5-­‐5	   139825559	   14123400	   5	   22	   Yes	  
KPL4	   PARP1-­‐ENSG00000227105	   1-­‐13	   226579911	   111589382	   1	   36	   No	  
MCF7	   FOXA1-­‐ENSG00000254868	   14-­‐14	   38061534	   38184710	   4	   50	   Yes	  
SKBR3	   SETD3-­‐CCDC85C	   14-­‐14	   99880270	   99880270	   5	   5	   Yes	  
BT474	   CEP250-­‐ZMYND8	   20-­‐20	   34078462	   45852969	   8	   58	   Yes	  
SKBR3	   SNTB1-­‐KLHDC2	   8-­‐14	   121561197	   50249311	   2	   5	   Yes	  
BT474	   ENSG00000229344-­‐ERBB2	   1-­‐17	   568761	   37880978	   2	   21	   No	  
BT474	   TTI1-­‐DIDO1	   20-­‐20	   36634798	   61569147	   1	   11	   Yes	  
MCF7	   RSBN1-­‐AP4B1	   1-­‐1	   114354329	   114442495	   6	   9	   Yes	  
BT474	   MCF2L-­‐LAMP1	   13-­‐13	   113718617	   113951809	   2	   6	   Yes	  
KPL4	   MUC20-­‐ENSG00000236833	   3-­‐3	   195456609	   197391652	   7	   12	   Yes	  
BT474	   GABRA3-­‐	  ZNF185	   X-­‐X	   151468339	   152114007	   1	   6	   Yes	  
SKBR3	   DIO2-­‐ENSG00000249517	   14-­‐14	   80669630	   80854020	   2	   4	   Yes	  
MCF7	   SULF2-­‐ARFGEF2	   20-­‐20	   46365685	   47538546	   21	   40	   Yes	  
BT474	   ENSG00000198744-­‐ATP5B	   1-­‐12	   569880	   57038738	   1	   13	   No	  
SKBR3	   EIF3H-­‐	  CYTH1	   8-­‐17	   117768257	   76778283	   19	   33	   Yes	  
SKBR3	   DHFR-­‐H19	   5-­‐11	   79946842	   2017318	   1	   6	   No	  
BT474	   WBSCR17-­‐FBXL20	   7-­‐17	   70958326	   37557613	   2	   7	   Yes	  
BT474	   ENSG00000225630-­‐HFM1	   1-­‐1	   570103	   91853140	   12	   42	   No	  
BT474	   HFM1-­‐DLG2	   1-­‐11	   91853144	   85195025	   2	   9	   No	  
KPL4	   EEF1DP3-­‐FRY	   13-­‐13	   32520314	   32652967	   2	   8	   Yes	  
BT474	   CMTM7-­‐GLB1	   3-­‐3	   32483331	   33055547	   2	   8	   Yes	  
MCF7	   ENSG00000224738-­‐TMEM49	   17-­‐17	   57184951	   57915655	   4	   9	   No	  
MCF7	   LRP1B-­‐PLXDC1	   2-­‐17	   142237963	   37265642	   2	   5	   Yes	  
KPL4	   ENSG00000249796-­‐MUC20	   3-­‐3	   195352201	   195456609	   7	   267	   No	  
MCF7	   PRRC2A-­‐ENSG00000224067	   6-­‐9	   31604384	   114565349	   2	   5	   No	  
KPL4	   SEPT10-­‐PPP1R12A	   2-­‐12	   110343414	   80211173	   4	   6	   Yes	  
MCF7	   CARM1-­‐SMARCA4	   19-­‐19	   11015626	   11097268	   2	   4	   Yes	  
BT474	   STARD3-­‐DOK5	   17-­‐20	   37793483	   53259996	   6	   10	   Yes	  
BT474	   MYO9B-­‐RAB22A	   19-­‐20	   17256206	   56886177	   8	   22	   Yes	  
SKBR3	   ENSG00000243185-­‐KRT18	   4-­‐12	   70296743	   53342904	   3	   14	   No	  
BT474	   PPP6R3-­‐SHANK2	   11-­‐11	   68228294	   70803333	   4	   12	   Yes	  
BT474	   MED1-­‐STXBP4	   17-­‐17	   37607290	   53218670	   13	   16	   Yes	  
MCF7	   ENSG00000233459-­‐ ZNF207	   2-­‐17	   204499953	   30692348	   1	   49	   No	  
KPL4	   BAG4-­‐ENSG00000255107	   8-­‐8	   38066752	   70771975	   1	   8	   No	  
SKBR3	   PKIA-­‐RARA	   8-­‐17	   79510592	   38465537	   1	   6	   Yes	  
BT474	   PCBD2-­‐UBB	   5-­‐17	   134259838	   16284410	   1	   5	   No	  
Table 4.2 TransFUSE detected 63 fusions, 34 of which are genuine fusions. 
Using four breast cancer cell lines (BT474, SKBR3, KPL4, MCF7), Edgren et al. [18] 
initially discovered 27 true fusion genes.  Later, the same research group (Kangaspeska et al. 




fusion genes.  The results include 34 out of the 40 true fusion genes.  The 25 fusions verified 
by Edgren et al. are shown in boldface, whereas the 9 fusions by Kangaspeska et al. shown in 
boldface and red. 
 
Figure 4.2 shows one example from TransFUSE’s output, a set of fusion and 
normal transcripts.  These transcripts presumably arise from the known fusion gene 
MRPL45-TRPC4AP and its wild type genes in the BT474 sample.  TransFUSE’s 
output includes depth coverage across the transcripts, the coordinates of the exons in 
each transcript, and the number of reads and pairs that map to each transcript.  
TransFUSE also provides a FPKM value, which represents the abundance of each 
transcript (FPKM stands for Fragments Per Kilobase of transcript per Million mapped 
fragments).  FPKM takes into consideration the length of a transcript in calculating 
the expression level of the transcript. 
Some of the fusion genes appear to be alternatively spliced.  For instance, 
SUMF1-LRRFIP2 from the SKBR3 sample has 3 fusion transcripts as illustrated in 
the first example of Figure 4.3.  The fusion transcripts #3 and #4 appear to have the 
same exons flanking of the fusion break point.  However, they have different 
transcript structures: #4 has one additional exon, #11, on the right partner gene 
TRPC4AP.  The fusion transcript #2 includes a left flanking exon different from those 
of #3 and #4.  It also involves a different splicing pattern on the right partner gene.  It 
is noteworthy that a fusion gene is expressed, while one or both of the two wild type 
genes may not be expressed.  For instance, the fusion gene IKZF3-VAPB (shown in 
the second example of Figure 4.3) produces three different fusion transcripts.  In 
contrast to the three normal transcripts expressed from a wild type gene VAPB, the 




Cufflinks-Fusion is able to assemble 33 fusions of the 34 known fusions in the 
four breast cancer samples.  A total of 17 fusions in the list are not assembled mostly 
because they do not have enough mapped reads or pairs to reconstruct transcripts.  
There may be too many other fusion break points nearby that conflict with the 
genuine one.  In this case, the assembly algorithm often chooses just a few of them 





Figure 4.2 A set of fusion and normal transcripts from a known fusion gene 
(MRPL45-TRPC4AP) and its wild type genes, generated by TransFUSE using a 




TransFUSE generates output in html format.  The figure is a part of the output.  There are 
four transcripts;  a transcript number is given on the left side of each transcript.  The first two 
of them are normal transcripts, most likely coming from a wild type MRPL45 (shown in red).  
The third one is a fusion transcript, and the last one is from a wild type TRPC4AP (shown in 
blue).  Red- and blue-colored boxes represent exons from MRPL45 and TRPC4AP, 
respectively.  Introns are indicated by thin black lines.  Coverage depths are shown in green.  
Exons, introns, and coverage depths are scaled to fit into the smaller display of the output.  
The order of exons in their respective transcripts is indicated by the small numbers below the 
bottom left corner of the exons.  These numbers facilitate reference to the genomic 
coordinates of the transcripts or exons in the table at the bottom (note that this number is not 
equal to the exon number).  The table also shows the number of pairs and reads that map to 








Figure 4.3 Two known fusion genes SUMF1-LRRFIP2 in SKBR3 sample and 
IKZF3-VAPB in BT474 sample are shown. 
The upper example shows six transcripts.  Three of them are normal transcripts, most likely 
coming from either wild type gene SUMF1 or LRRFIP2.  The others are fusion transcripts.  
The fusion transcripts #3 and #4 appear to have the same flanking exons in common, but it 
has different transcript structures where #4 transcript has one additional exon, #11.  The 
fusion transcript #1 includes a left flanking exon different from those of #3 and #4.  The 
fusion gene IKZF3-VAPB at the bottom produces three different fusion transcripts.  While 
three normal transcripts are made from a wild type gene VAPB, the other wild type IKZF3 





For the lung cancer cell sample (LC_S42), we found 8 fusion candidates in 





Fusion	  genes	  (left-­‐right)	   Chromosomes	  
(left-­‐right)	  






LC_S42	   HEBP2-­‐VTA1	   6-­‐6	   138734016	   142525201	   118	   52	   Yes	  
LC_S42	   KIF5B-­‐RET	   10-­‐10	   32317355	   43612031	   57	   13	   Yes	  
LC_S42	   ENSG00000211653-­‐IGLL5	   22-­‐22	   22764609	   23235959	   15	   32	   Yes	  
LC_S42	   CCT2-­‐LGR5	   12-­‐12	   69987392	   71835366	   131	   28	   Yes	  
LC_S42	   NMBR-­‐CPM	   6-­‐12	   142400039	   69326457	   23	   14	   Yes	  
LC_S42	   HECA-­‐CPM	   6-­‐12	   139491700	   69326457	   62	   50	   Yes	  
LC_S42	   OVCH2-­‐LOC283299	   11-­‐11	   7726220	   7900553	   2	   4	   Yes	  
LC_S42	   INS-­‐COIL	   11-­‐17	   2153283	   55015815	   2	   2	   Yes	  
LC_S42	   KIF5B-­‐RET	   10-­‐10	   32311963	   43610099	   6	   3	   Yes	  
Table 4.3 Fusions found by TransFUSE using one lung cancer cell sample 
(LC_S42). 
Seo, Ju, Lee et al. [63] previously reported one fusion gene KIF5B-RET (shown in boldface).  
Note that there is another fusion gene candidate KIF5B-RET at the 9th row.  This fusion gene 
is different from the one at the 2nd row in terms of the location of a fusion break point and in 
that different strands of the two genes are combined forming the fusion gene. 
 
4.4 Conclusions 
TransFUSE augments our previous fusion-finding program, TopHat-Fusion 
(now a part of TopHat2) with additional functionalities such as assembling and 
quantifying fusion and normal transcripts that together comprise isoforms of a fusion 
gene and its wild type genes.  Previous results from TopHat-Fusion [19] 
demonstrated it is highly sensitive and its false positive rate is relatively low.  With 
more evidence available from TransFUSE, such as several isoforms of a fusion gene 
and the expression levels of transcripts, we can sort fusion candidates in a fashion that 
fusions with more evidence appear before those with less evidence.  This can help 
biologists quickly interpret the data and decide which fusions to address first.  Unlike 




locations of break points), TransFUSE provides detailed information about full-length 
fusion transcripts.  These capabilities enable one to infer the potential function of a 
fusion gene by examining the participating exons of the transcripts and their splicing 
patterns and perhaps to identify a basis for the underlying causes of diseases.  
Expression levels of fusion genes may also be compared with those of normal 
transcripts from wild type genes to provide additional insight. 
 




Fusion	  genes	  (left-­‐right)	   Chromosomes	  
(left-­‐right)	  




BT474	   TRPC4AP-­‐MRPL45	   20-­‐17	   33665850	   36476499	   2	   9	  
BT474	   TOB1-­‐SYNRG	   17-­‐17	   48943418	   35880750	   26	   47	  
SKBR3	   TATDN1-­‐GSDMB	   8-­‐17	   125551264	   38066175	   311	   555	  
BT474	   THRA-­‐SKAP1	   17-­‐17	   38243102	   46384689	   28	   46	  
MCF7	   BCAS4-­‐BCAS3	   20-­‐17	   49411707	   59445685	   105	   284	  
BT474	   ACACA-­‐STAC2	   17-­‐17	   35479452	   37374425	   57	   59	  
BT474	   STX16-­‐RAE1	   20-­‐20	   57227142	   55929087	   6	   24	  
BT474	   MED1-­‐ACSF2	   17-­‐17	   37595419	   48548386	   10	   12	  
MCF7	   ENSG00000254868-­‐FOXA1	   14-­‐14	   38184710	   38061534	   2	   22	  
SKBR3	   ANKHD1-­‐PCDH1	   5-­‐5	   139825557	   141234002	   4	   15	  
BT474	   ZMYND8-­‐CEP250	   20-­‐20	   45852972	   34078459	   10	   53	  
BT474	   AHCTF1-­‐NAAA	   1-­‐4	   247094879	   76846963	   10	   42	  
SKBR3	   SUMF1-­‐LRRFIP2	   3-­‐3	   4418012	   37170638	   3	   12	  
KPL4	   BSG-­‐NFIX	   19-­‐19	   580779	   13135832	   12	   27	  
BT474	   VAPB-­‐IKZF3	   20-­‐17	   56964574	   37922743	   4	   14	  
BT474	   DLG2-­‐HFM1	   11-­‐1	   85195025	   91853144	   2	   10	  
SKBR3	   CSE1L-­‐ENSG00000236127	   20-­‐20	   47688988	   47956855	   13	   31	  
MCF7	   RSBN1-­‐AP4B1	   1-­‐1	   114354329	   114442495	   6	   7	  
BT474	   MED13-­‐BCAS3	   17-­‐17	   60129899	   59469335	   3	   14	  
MCF7	   ARFGEF2-­‐SULF2	   20-­‐20	   47538545	   46365686	   17	   20	  
BT474	   HFM1-­‐ENSG00000225630	   1-­‐1	   91853144	   565937	   2	   43	  
KPL4	   MUC20-­‐ENSG00000249796	   3-­‐3	   195456606	   195352198	   13	   46	  
KPL4	   MUC20-­‐ENSG00000236833	   3-­‐3	   195456612	   197391649	   8	   15	  
MCF7	   RPS6KB1-­‐TMEM49	   17-­‐17	   57992061	   57917126	   4	   3	  
SKBR3	   WDR67-­‐ZNF704	   8-­‐8	   124096577	   81733851	   3	   3	  
BT474	   CPNE1-­‐PI3	   20-­‐20	   34243123	   43804501	   2	   6	  
BT474	   ENSG00000229344-­‐RYR2	   1-­‐1	   568361	   237766339	   1	   19	  
BT474	   LAMP1-­‐MCF2L	   13-­‐13	   113951808	   113718616	   2	   6	  
MCF7	   SULF2-­‐ZNF217	   20-­‐20	   46415146	   52210647	   11	   32	  
BT474	   WBSCR17-­‐FBXL20	   7-­‐17	   70958325	   37557612	   2	   8	  
MCF7	   ENSG00000224738-­‐TMEM49	   17-­‐17	   57184949	   57915653	   5	   6	  




BT474	   ENSG00000251948-­‐SLCO5A1	   19-­‐8	   24184149	   70602608	   2	   6	  
BT474	   GLB1-­‐CMTM7	   3-­‐3	   33055545	   32483333	   2	   6	  
KPL4	   EEF1DP3-­‐FRY	   13-­‐13	   32520314	   32652967	   2	   4	  
MCF7	   PAPOLA-­‐AK7	   14-­‐14	   96968936	   96904171	   3	   3	  
BT474	   ZNF185-­‐GABRA3	   X-­‐X	   152114004	   151468336	   2	   3	  
KPL4	   PPP1R12A-­‐SEPT10	   12-­‐2	   80211173	   110343414	   3	   8	  
BT474	   SKA2-­‐MYO19	   17-­‐17	   57232490	   34863349	   5	   12	  
MCF7	   LRP1B-­‐PLXDC1	   2-­‐17	   142237963	   37265642	   2	   5	  
BT474	   NDUFB8-­‐TUBD1	   10-­‐17	   102289117	   57962592	   1	   49	  
BT474	   ENSG00000225630-­‐
NOTCH2NL	  
1-­‐1	   565870	   145277319	   1	   18	  
SKBR3	   CYTH1-­‐EIF3H	   17-­‐8	   76778283	   117768257	   18	   37	  
BT474	   PSMD3-­‐ENSG00000237973	   17-­‐1	   38151673	   566925	   1	   12	  
BT474	   STARD3-­‐DOK5	   17-­‐20	   37793479	   53259992	   2	   10	  
BT474	   DIDO1-­‐TTI1	   20-­‐20	   61569147	   36634798	   1	   10	  
BT474	   RAB22A-­‐MYO9B	   20-­‐19	   56886176	   17256205	   8	   20	  
KPL4	   PCBD2-­‐ENSG00000240967	   5-­‐5	   134259840	   99382129	   1	   32	  
SKBR3	   RARA-­‐PKIA	   17-­‐8	   38465535	   79510590	   1	   5	  
BT474	   MED1-­‐STXBP4	   17-­‐17	   37607288	   53218672	   13	   11	  
KPL4	   C1orf151-­‐ENSG00000224237	   1-­‐3	   19923605	   27256479	   1	   5	  
SKBR3	   RNF6-­‐FOXO1	   13-­‐13	   26795971	   41192773	   2	   13	  
SKBR3	   BAT1-­‐ENSG00000254406	   6-­‐11	   31499072	   119692419	   2	   30	  
BT474	   KIAA0825-­‐PCBD2	   5-­‐5	   93904985	   134259811	   1	   19	  
SKBR3	   PCBD2-­‐ANKRD30BL	   5-­‐2	   134263179	   133012790	   1	   5	  
BT474	   ENSG00000225630-­‐
MTRNR2L8	  
1-­‐11	   565457	   10530147	   1	   35	  
BT474	   PCBD2-­‐ENSG00000251948	   5-­‐19	   134260431	   24184146	   2	   6	  
BT474	   ANKRD30BL-­‐
ENSG00000237973	  
2-­‐1	   133012085	   567103	   2	   8	  
KPL4	   ENSG00000225972-­‐
HSP90AB1	  
1-­‐6	   564639	   44220780	   1	   7	  
BT474	   MTIF2-­‐ENSG00000228826	   2-­‐1	   55470625	   121244943	   1	   11	  
BT474	   ENSG00000224905-­‐PCBD2	   21-­‐5	   15457432	   134263223	   2	   7	  
BT474	   RPS6KB1-­‐SNF8	   17-­‐17	   57970686	   47021335	   48	   57	  
BT474	   MTRNR2L8-­‐PCBD2	   11-­‐5	   10530146	   134263156	   1	   6	  
BT474	   RPL23-­‐ENSG00000225630	   17-­‐1	   37009355	   565697	   3	   19	  
BT474	   MTRNR2L2-­‐PCBD2	   5-­‐5	   79946288	   134259832	   1	   5	  
SKBR3	   ENSG00000240409-­‐PCBD2	   1-­‐5	   569005	   134260124	   2	   4	  
SKBR3	   PCBD2-­‐ENSG00000239776	   5-­‐12	   134263289	   127650986	   2	   3	  
BT474	   ENSG00000239776-­‐
MTRNR2L2	  
12-­‐5	   127650981	   79946277	   2	   3	  
BT474	   JAK2-­‐TCF3	   9-­‐19	   5112849	   1610500	   1	   46	  
KPL4	   NOTCH1-­‐NUP214	   9-­‐9	   139438475	   134062675	   3	   5	  
BT474	   MTRNR2L8-­‐TRBV25OR92	   11-­‐9	   10530594	   33657801	   4	   4	  
BT474	   MTRNR2L8-­‐AKAP6	   11-­‐14	   10530179	   32953468	   1	   5	  
BT474	   ENSG00000230916-­‐PCBD2	   X-­‐5	   125606246	   134263219	   1	   5	  
MCF7	   ENSG00000226505-­‐MRPL36	   2-­‐5	   70329650	   1799907	   5	   20	  
SKBR3	   CCDC85C-­‐SETD3	   14-­‐14	   100002351	   99880270	   5	   6	  
BT474	   RPL23-­‐ENSG00000230406	   17-­‐2	   37009955	   222457168	   109	   5	  
Table 4.4 76 fusions initially identified by TopHat-Fusion. 
This table was excerpted from the TopHat-Fusion paper [19], Table 2 and modified as 
follows.  This is a list of 76 of fusion gene previously predicted by TopHat-Fusion at which 
time 24 of them were known to be true (shown in boldface).  Additional 9 new fusion genes 





Chapter 5:  A proposal for a new RNA-seq alignment pipeline 
 
5.1 Limitations of current approaches to the problem of RNA-seq alignment 
Chapter 2 covered two popular methods of aligning RNA-seq reads against 
the reference genome.  Many alignment programs employ a one-step approach in 
which a read is aligned independently of other reads.  Most aligners rely on k-mer 
(usually with k >10 bp) mapping to initially identify potential read origin locations in 
the genome.  Some of the reads are easily aligned with this approach when they have 
enough bases (>= k) around splicing events or indels.  For such reads, we can 
effectively narrow down the range where events lie, as reads' k-mer mapping allows 
us to identify the left and right boundaries between which these events fall.  However, 
other reads that have few bases on either side of such events are extremely hard or 
inefficient to align due to the short anchors.  Thus, this approach tends to misalign or 
fail to align those short-anchored reads.  This is a nontrivial issue for RNA-seq 
alignment, considering a significant portion of reads (e.g., about 20% of 100-bp 
reads) is estimated to have at most a 10-bp anchor on either side of the introns.  In 
contrast, some other aligners such as TopHat and MapSplice use a two-step approach.  
First, they find and collect splice sites using reads that have a sufficient amount of 
bases around them.  The sequences flanking the splice sites then are glued together, 
producing spliced sequences.  Second, reads lacking sufficiently long anchors are 
aligned against the spliced sequences, and then their “transcriptomic” coordinates are 
converted into the corresponding genomic coordinates.  This two-step approach 




However, this is at the cost of much more I/O processing and time due to the two 
alignment steps: initial alignments of the reads and subsequent alignments of those 
initially unmapped reads. 
 
Figure 5.1 Limitations of TopHat2 pipeline 





























































































In addition to these inherent limitations of the two-step approach, TopHat2 
has its own specific issues this suggests room for further improvement.  First, it is 
hard to detect indels near splice sites.  TopHat2 works well for simpler cases in which 
reads include just one event.  With a high coverage of reads, we can expect reads with 
enough anchors around such an event.  TopHat2 splits the reads into several small 
non-overlapping segments with a default length of 25 bp.  Then, by mapping 
segments, TopHat2 can identify the small range where the event is located.  It can 
also use the unmapped segments of the reads to pinpoint the precise location of the 
event (see Chapter 2 for more details).  However, this is no longer the case when 
reads span two exons with an indel close to the splice site between them.  For the sake 
of the discussion, it is inconsequential whether the indel is an insertion or a deletion 
for the sake of the discussion.  As mentioned previously, TopHat2 requires at least 
two segments of reads  to be aligned, where one segment is on the left side of the 
event and the other on the right.  However, if an insertion or a deletion is <= 25 bp 
away from a splice site, it is unlikely in most cases that we have the requisite two left 
and right segments to be aligned.  To provide a more concrete understanding, let us 
consider a read (shown in read) consisting of three segments (left, middle, and right) 
in Figure 5.1 (1).  This read is initially unmappable because it involves two exons, 
and the right exon contains an indel.  The read is subsequently split into three 
segments, and only one of them is mapped.  This mapping does not satisfy the two-
segment mapping condition; therefore, TopHat2 is not able to detect the splicing 
event or the indel.  This prohibits the read from aligning.  It is also hard to find small 




5.1 (2), TopHat2 aligns segments independently, without using information other 
segments’ mapped locations.  Short segments can map to too many locations; in a 
highly repetitive genome like the human genome, segments can map to hundreds or 
even thousands of locations.  TopHat 2 imposes a certain limit on the number of 
locations a segment can map to, in order to prevent itself from producing large 
intermediate files for the segment alignment and consuming too much time searching 
for all possible alignments.  As a result of the limit, reads containing such repetitive 
segments may not be aligned by TopHat2.  On the other hand, the segment mapping 
would be more efficient if we make use of other segments’ alignment location.  For 
instance, if we know some segments of reads are perfectly or nearly perfectly aligned 
to only a few locations, we may narrow down the search space for the other segments 
near these locations.  This will likely to make it easier and more efficient to find the 
correct locations for segments and pinpoint the events that reads contain. 
 
5.2 A new pipeline for RNA-seq alignment 
In the previous section, we mentioned the limitations of TopHat2; primarily, 
its segment mapping.  First, in case of reads containing more than one event (e.g. one 
splice site with one insertion close), TopHat2 may not be able to locate the events.  
Even if two segments are mapped, it may involve a very slow search to identify these 
events, possibly using dynamic programming algorithm such as Needleman-Wunsch 
[64] and Smith-Waterman [65].   However, implementing this algorithm is nontrivial.  
We realized that Bowtie2 includes a very efficient implementation of such an 




(SIMD) parallel processing, which is significantly faster and is available on modern 
CPUs [66, 67].  Second, TopHat2 aligns segments independently, without using 
information other segments’ mapped locations.  The segment mapping would be more 
efficient if we make use of other segments’ alignment location.  For instance, if we 
know some segments of reads are perfectly or nearly perfectly aligned to only a few 
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Here, we suggest a new pipeline for RNA-seq alignment, which would 
incorporate TopHat2’s segment alignment and detection of splicing events, indels, 
and fusions into Bowtie2.  As we have discussed previously, Bowtie 2 has already 
implemented some algorithms that can be modified to efficiently handle these issues. 
There are three core steps at the heart of the new pipeline, as illustrated in Figure 5.2.  
As the first step of the new pipeline, Bowtie 2 can be modified and enhanced to 
identify splice sites and indels.  Then, it will report the events with some evidence, 
such as the number of reads supporting those events (see Figure 5.2 (1)).  These 
events can be used to reconstruct transcripts being observed in samples sequenced.  
Unlike the problem of the reconstruction of full-length transcripts, we only need to 
reconstruct partial transcripts as long as a read that is supposed to map to a full-length 
transcript is mapped to at least one partial transcript that is part of the full-length 
transcript as illustrated in Figure 5.2 (2).  While reconstructing full-length transcripts 
involves exponential combinations of splicing events, partial transcripts involve 
dramatically fewer combinations.  Similarly, we can create partial transcripts that 
include indels as well as fusion transcripts.  As shown in Figure 5.2 (3), in contrast to 
the genome alignment, this transcriptome alignment will make Bowtie2 to focus on 
just base-level mismatches or indels introduced in the sequencing steps.  A further 
advantage is this alignment step is likely very fast because this transcriptome is 
usually expected to comprise just a small percentage of the whole genome.  Finally, 
the transcriptomic coordinates of read alignments are converted into the 






Figure 5.3 Two core algorithms of the new pipeline 
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Here, we elaborate on two main ideas: (1) Bowtie2 enhancements to identify 
splicing events, indels, and fusion break points and (2) reconstruction of partial 
transcripts using the events.  As illustrated in Figure 5.3 (1), the left read of the 
fragment shown in red involves two events, one splicing event with one indel being 
close.  In order to find these events, Bowtie2 can split the read into segments (or 
“seeds” in the Bowtie terminology) with shorter length (between 10 and 20 bp), 
where segments can overlap with some others.  Unlike TopHat2’s segment mapping 
(longer segment – 25 bp and non-overlapping segments), this will increase chance to 
anchor more segments near these events.  Once we detect some discrepancies 
between two segments, that is, the genomic distance between their mapped locations 
is different from that distance between their positions in the read, we can apply a 
modified version of Bowtie2’s SIMD-accelerated dynamic algorithm using to identify 
those events.  The results from this algorithm are a list of events with some evidence 
such as the number of reads supporting them.  Based on the list, we can reconstruct 
partial transcripts instead of trying to build full-length ones.  We need to ensure that a 
read that was supposed to map to a full-length transcript is mapped to one partial 
transcript, which is a part of the full-length transcript.  For instance, shown in Figure 
5.3 (2), instead of producing a four-exon transcript (e1-e2-e3-e4), we can generate 
two partial transcripts: e1-e2-e3 and e2-e3-e4.  For the alternative splicing event 
between e1 and either e2 or e3, we can produce an additional transcript, e1-e3-e4.  
For the indel event, two additional transcripts are constructed: e1-e2’-e3 and e2’-e3-
e4, where e2’ is the identical copy of the exon e2 except the indel.  Constructing 




transcripts involves exponential combination of splicing events, indels, and fusion 








Chapter 6: Conclusions 
 
RNA-seq technologies provide us with tremendous opportunities to 
investigate the structure and abundance of transcripts, differential expression, 
structural variations, and more.  It also delivers high throughput data within just a few 
days at progressively lower costs.  This enables us to investigate genetic programs 
and cellular activities with precision, accuracy, and speed.  However, in order to 
effectively use RNA-seq reads they generate, the sequencing technologies require 
new computational methods.  In this thesis, I have designed novel algorithms and 
implemented several software systems to tackle these new challenges. 
First, mapping reads to the genome is an essential step in RNA-seq analyses; 
the accuracy of mapping software can determine the accuracy of downstream steps 
such as gene and transcript discovery or expression quantification.  I have developed 
TopHat2, which provides major improvements in accuracy over previous versions of 
TopHat and other RNA-seq mapping tools.  In order to find the location information, 
reads may be aligned against the reference genome.  However, RNA-seq reads pose 
new challenges because they may span multiple splice sites rather than just one or 
two.  We estimate that nearly half of reads 150-bp long would span two or more 
human exons.  The algorithmic improvements in TopHat2 address this challenge, 
maintaining both accuracy and speed.  TopHat2 also avoids erroneously mapping 
reads to pseudogenes by making effective use of available gene annotations.  This 




RNA-seq also enables us to discover structural variations, including genomic 
rearrangements.  I have developed TopHat-Fusion, which detects fusion break points 
and map reads against them.  Unlike previous approaches based on discordantly 
mapping paired reads and known gene annotations, TopHat-Fusion can find either 
individual or paired reads that span gene fusions, and it runs independently of known 
genes.  This improves its sensitivity and enables it to find fusions including novel 
genes and novel splice variants of known genes.  I have developed TransFUSE to 
further expand the analysis of fusion events by allowing the reconstruction and 
expression estimation of fusion transcripts.  TransFUSE makes available more 
evidence, such as isoforms of fusion genes and estimates of their expression levels.  
As a result, we can put fusion candidates in order, those with more evidence first and 
those with less evidence after.  This can help biologists quickly interpret the data and 
decide which fusions to address first.  In contrast to previous approaches that simply 
provide a list of candidate fusions (genomic locations of break points), TransFUSE 
provides detailed information about full-length fusion transcripts such as exons, 
introns, and fusion break points.  These capabilities enable one to infer the potential 
function of a fusion gene by examining the participating exons of the transcripts and 
their splicing patterns.  Such analysis will help scientists identify the genetic basis of 
diseases.  Expression levels of fusion genes may also provide additional insight when 
compared with those of normal transcripts from wild type genes. 
I have shown that TopHat2, TopHat-Fusion, and TransFUSE perform well 
over a wide range of read lengths.  This ability makes these programs a good fit for 




by many biologists, we expect that such experiments, in conjunction with these 
software systems, will provide scientists with accurate results for use with expression 
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